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General Introduction
Perinatal mortality is often seen as a quality parameter for obstetric and neonatal
care.1The past decades have shown a strong decline in perinatal mortality in the
industrialized western world from 3% to 0.5%.2,3
The perinatal mortality rate (> 28 weeks) for the Netherlands is about 0.7%,
meaning a total of approximately 1400 cases of perinatal death per year.4This means
a loss of approximately 4 children a day! These figures are higher than the number of
lethal traffic accidents a year in the Netherlands (source:Central Statistics Office).
Good perinatal care is associated with low perinatal mortality figures as was shown
in Scandinavian countries.3 A low perinatal mortality figure however does not
automatically mean that the quality of the delivered care is high.There are two other
important factors that matter, considering the level of perinatal mortality: the
definition of perinatal mortality and the reliability of the registration. A dissertation
about perinatal mortality can not ignore these aspects.
Concerning the reduction of perinatal mortality figures, a genuine lowering is only
realized under the circumstances that the definition does not change and that the
registration is complete. Apart from this a knowledge of the causes of perinatal
death and of risk factors related with perinatal death may attribute to the reduction
of that mortality.We deal with these aspects of perinatal mortality in this thesis, and
we hope it gives an impulse to the reduction of perinatal mortality.The first part
draws attention to the registration in the Netherlands, the second part to the
classification of causes of death and the third part to risk factors for perinatal death.
Definition and Registration
It appears to be difficult to compare national perinatal mortality figures. First of all
there exists a problem in the definition of perinatal mortality in national and
international perspective.The World Health Organisation (WHO) recommended in
1977:‘For international statistics the term perinatal death should include early
neonatal deaths (< 7 days postnatally) together with those fetal deaths of weight
1000 grams or more,or if weight is unknown a gestational age of 28 weeks or more
or a crown-rump-length of 35 cm or more.’5 In 1992 the WHO introduced the 10th
revision of the International Classification of Diseases (ICD-10) which defines for
perinatal mortality the period commencing at 22 completed weeks of gestation (the
time birth weight is normally about 500 grams) and ending within 7 days postnatally.6
Many countries use different definitions from these WHO recommendations. For
example Norway takes as a cut-off point a menstrual age of 16 weeks for live births
(including late abortions), Iceland a menstrual age of 20 weeks and Switzerland a
fetal crown-rump-length of 30 cm.7
In the Netherlands since July 1991 all still- and liveborn children from 24 weeks
onwards and children who died within 7 days postnatally are included in the national
perinatal death figures and recorded by the Central Statistics Office (CBS). So one
can conclude that the criteria for stillbirth differ internationally both in parameters:
menstrual age,birth weight, crown-rump length, as for cut-off points:Menstrual age
16,20,22,24 or 28 weeks,birth weight 500 or 1000 grams.8 The cut-off points for
early neonatal death are varying between:within the first week,< 7 days,within 7 x
24 hours, and for late neonatal death from 7 completed days to < 1 month,< 28 days
and ≤ 28 days.These differences between countries have a substantial impact on the
officially published perinatal mortality rates.
Under ideal circumstances,when uniform internationally accepted definitions for
perinatal mortality are handled, there remain problems in the completeness of the
registration. In 1985 Doornbos et al. showed underreporting in Amsterdam in 14.3%
of the cases.Characteristics of the cases that were not registered were a low birth
weight,menstrual age on the borderline of registration duty, lethal congenital
malformations and parents with a non-western background.
Obstetric care in the Netherlands contrasts with the care in surrounding countries
with regard to two conspicuous phenomena,namely home confinement and the
relatively low (especially as compared to Australia and the United States of America)
frequency of assisted deliveries.9 Firstly, it is possible to deliver under primary care
at home or in an outpatients’ clinic,without involvement of an obstetrician,but
under the supervision of a midwife and in some areas, a general practitioner.This is
an almost unique situation in the civilised western world,which – unlike the
situation in the developing countries – arises from a conscious decision to do so.
One may wonder which consequences this unique organization of obstetrics in the
Netherlands has  for the quality of the obstetric care.This question is raised both
nationally and internationally and is important because of the suggested  less rapid
decrease in perinatal mortality rates in comparison to the countries around us .2,7
After adjustment for gestational age the Netherlands proved to be twelfth in the
table of 15 European countries.4 Some authors suggest that these presumed higher
perinatal mortality figures result from higher percentages of home confinements as
compared to hospital deliveries.10 As long as differences in countries’ published
perinatal mortality rates partly reflect differences between criteria for registration
and publication of perinatal deaths it is impossible to make these conclusions. A
uniform definition and reliable registration is of utmost importance.
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Classification of causes of perinatal death 
Registration of the causes of perinatal death is not frequently used although various
classification systems are available.This can be explained by the fact that most
classifications are not based on the underlying pathological process, leading to a high
percentage of ‘unexplained’ cases.11,12
For the registration of causes of perinatal death, the CBS uses the ‘International
Classification of Diseases 10’ (ICD-10).13 However, little is known about the
reliability of the CBS registration of these causes.
Classifying causes of perinatal death may bring to light differences in the occurrence
of causes of perinatal mortality in different areas.
The main purpose of a classification system should be to shed light on the perinatal
events and to be an aid on future management.However many classification systems
throw up a high percentage of ‘unexplained’ cases and so fail to help in the quest to
understand and  to reduce perinatal mortality.Often ‘unexplained’ is seen as
synonymous with ‘unavoidable’, resulting in the conclusion that nothing can be done.
A classification system based on the underlying causes of perinatal death can be a
contribution to the discussion concerning suboptimal factors in perinatal care.14
Risk factors for perinatal mortality
Perinatal mortality can be lowered  by improving perinatal care if risk factors for
perinatal mortality can be traced and adequate preventive measures are available.
Maternal thrombophilia is considered to be such a risk factor.Thrombophilia,
defined as acquired or inherited predisposition to thrombosis is seen in women
with pregnancy associated thrombo-embolism,but also in other vascular
complications of pregnancy, including preeclampsia,15 intra-uterine growth
retardation, abruptio placentae,16,17 recurrent miscarriage18-21 and late fetal loss.22-24
Thrombophilia can be considered as a familial disease.The paternal role in the
occurrence of  preeclampsia was suggested by Lie et al. in a study showing the
association between preeclampsia and changing paternity.25 A recent study found
evidence for paternal as well as maternal components to preeclampsia.26 In perinatal
mortality however the paternal role in thrombophilia was still unclear.
Main objectives of this thesis were:
1. To study the registration of perinatal mortality figures and causes of death in a
Dutch healthcare region, considered to be representative for the Netherlands;
2. To establish the distribution of perinatal mortality over the various levels of
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obstetric care in the Netherlands, taking into account the causes of perinatal
mortality;
3. To develop and validate a classification model based upon ‘the most probable’
underlying cause of death;
4. To study risk factors for perinatal death,not only in women but in their male
partners as well.
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Part 1
R E G I S T R AT I O N  I N  T H E  D U T C H
O B S T E T R I C  C A R E  S YS T E M
Introductory remarks
In this part of the thesis the used definition for perinatal mortality was according to
the CBS definition before July 1991:
- Stillborn children ≥ 28 completed weeks of gestation.
- Live born children who died within the first week after delivery.
This definition is advised for the national registration of perinatal mortality in the
Netherlands. As the studies in chapter 2 and 3 are published in the Dutch Medical
Journal this CBS definition was used.The study was performed between 1995 and
1997.
A total number of 247 cases of perinatal mortality fulfilling the criteria of the CBS
were registered and used in both studies as described in chapters 2 and 3.
The authors AG, JK,DV and YO classified the causes of death according to a
modified division after Hovatta in comparison to the International Classification of
Diseases 9 (ICD-9) of the CBS.
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Chapter 2
Discrepancies between the results of the registration of
causes of perinatal death by the Netherlands Central
Statistics Office and personal investigation in the region of
Delft-Westland-Oostland
A.E.M.de Galan-Roosen, J.C.Kuijpers,Y.B.Oei,D. van Velzen, J.P.Mackenbach
Ned Tijdschr Geneeskd  1997;141 (5) : 237-240
Abstract
Objective:To determine the reliability of the Dutch registration of causes of perinatal
death by the Centraal Bureau voor de Statistiek (CBS,Central Statistics Office).
Design: Prospective,descriptive.
Setting:Region Delft-Westland-Oostland, the Netherlands.
Material and methods:The registration was based on data concerning all deliveries of
women domiciled in the region, irrespective of the ultimate place of delivery,during
1983-1992.By linking, in retrospect, a prospective regional registration system for
perinatal mortality within the region anonymously to the CBS registration, the
reliability of the latter registration with regard to the causes of death was
determined.To establish the causes of death, a team consisting of a gynaecologist, a
paediatrician and a paediatric pathologist assessed all available data.The diagnoses
were classified with the aid of the International Classification of Diseases 9 (ICD-9).
Results: In 10 years, 28,983 children were born in the region.Over this period, the
CBS recorded 227 cases of perinatal mortality.The actual perinatal mortality was
calculated as at least 247 cases. In 32% of the cases of stillbirth, the cause of death
was not known at the CBS.Of the 82 cases in which the CBS had recorded a
diagnosis, the causes of death were in agreement with those found in the regional
study in 46%.With regard to first-week mortality, the diagnosis was unknown at the
CBS in one case and of the remaining 76 cases, the registration of the cause of death
was the same in 68% of the cases.
Conclusions: Registration of the causes of death regarding perinatal mortality and
particularly stillbirth by the CBS shows gaps,mostly due to incorrect reporting of
the cause of death by the treating physician or autopsist, due to the fact that at the
time of notification the morbid-anatomical diagnosis and/or laboratory data were
not complete. For a comprehensive study of the backgrounds of perinatal mortality,
the current CBS registration appears unsuitable.
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Introduction
From the 1st of July 1991, the official notification requirement regarding all still- and
live-born children changed to the extent that it now applies to a period of
pregnancy ≥ 24 weeks – previously ≥ 28 weeks – for stillborn children;no period of
time applied to children born alive.The methods of notification and registration have
already been explained in detail.
1-4
The reliability of perinatal mortality registrations
in the Netherlands depends largely upon the correct completion of forms A and B
respectively. Form A is considered to be a ‘judicial declaration of death’ for the
Registrar of Births,Deaths and Marriages, and is processed as a numeric notification
by the Centraal Bureau voor de Statistiek (CBS,Central Statistics Office). Form B,
the so-called yellow form, is intended to be the ‘cause of death’ certificate for the
CBS’ medical officer.2
The purpose of a registration of the causes of perinatal death is to facilitate the
analysis of  the causes of perinatal death within a population through examining the
underlying pathological process, and to research the possibilities of intervention in
the future.Various classification systems are used for this analysis.5,6
The CBS in the Netherlands uses the ‘International Classification of Diseases 9’
(ICD-9)7, for its registration of causes of perinatal death.However, little is known
about the reliability of the CBS registration.The purpose of our research was to
establish that reliability in practice.
Data and methods
During the period 1983 - 1992, a prospective analysis of perinatal death was carried
out in the region of Delft-Westland-Oostland (DWO) with approximately 215,000
inhabitants. For the purpose of this research, the region DWO was construed as
done by the Coördinatie Commissie Regionaal Onderzoeksprogramma
(Co-ordination Committee Regional Research;number 27 in the program) and
expanded to include Nootdorp.The region included the Municipalities:Delft,
‘s-Gravenzande,De Lier,Maasland,Monster,Naaldwijk,Nootdorp,Pijnacker,
Schipluiden and Wateringen.Our study involved data pertaining to the deliveries of
all women residing in the region, regardless of the final place of delivery.Next to
numerical registration, the registration of causes of death was particularly
investigated.
In order to obtain a complete summary of perinatal death in the region, a number of
registration systems were used.The Reinier de Graaf Gasthuis in Delft is the only
hospital in the region and is situated centrally, so that it attracts the majority of cases
of obstetric care (table 1).
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Three Reinier de Graaf Gasthuis’ hospital registration systems were consequently
used as the primary source:
1. The local version of the Landelijke Verloskunde Registratie (Perinatal Database
of the Netherlands);
2. A manually updated registration of ante-partum transfers from the Reinier de
Graaf Gasthuis to hospitals with a neonatal intensive care unit;
3. A pathology registration system for perinatal autopsies from the region.
Furthermore,data from all transfers of new-born children born in the Reinier de
Graaf Gasthuis, co-ordinated by the Neonatology department of the Academisch
Ziekenhuis Leiden (Leiden University Hospital) were investigated.
In addition to this, the CBS registration was consulted for all deliveries of children
born alive, stillborn children and children who died within the first week postpartum
from the DWO region, including home deliveries and clinical deliveries that took
place outside the DWO region (source:Population Statistics Department S1 of the
CBS).
Clinical data regarding pregnancy,parturition and childbirth in all cases of perinatal
mortality (stillborn ≥ 28 weeks,neonatal death within the first week postpartum)
from the region were recorded in a data file, along with neonatal data.These data
were completed with autopsy results (carried out in 78% of the cases), histological
examination of the placenta and additional laboratory research. In consultation with
gynaecologist and paediatrician on the one hand, and fetal pathologist on the other,
the most likely cause of death was established per case using the ICD-9 classification
that is also used by the CBS for the registration of causes of death.
After anonymous linking with the aid of the child’s date of birth and the mother’s
Chapter 2
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Table 1
Place of delivery of women residing in the region Delft- Westland-Oostland,1983-1992
(n= 28,983)
number of deliveries (%)
Reinier de Graaf Gasthuis Delft 16,904 (58)
secondary care 13,082
primary care in the hospital 3,822
at home 10,997 (38)
outside the region of Delft-Westland-Oostland*
secondary care elsewhere and tertiary care 1,082 (4)
total 28,983 (100)
* Including 65 ante-partum transfers to tertiary care outside the region.
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age and place of residence, these data were compared to the causes of death
registered by the CBS.For this, a division in the subgroups of the ICD-9 was used.
Results
During the 10 year period (1983 - 1992), 28,983 children were born in the DWO
region.The CBS registration listed 227 cases of perinatal death (stillborn ≥ 28
weeks,neonatal death during the first week postpartum). In addition to this, 20
cases of perinatal death unknown to the CBS could be established by consulting the
additional Reinier de Graaf registrations.These cases included 17 cases of stillbirth
and 3 cases of death during the first week postpartum,with characteristics such as
duration of amenorrhea bordering on the official notification requirement (8),
serious congenital defects (6), home parturition (1), very low birth weight (1), and
other (4).Therefore, a total of 247 cases of perinatal death were found.
For 198 cases, recorded in the registrations by both the CBS and the regional
research, sufficient data were available to make a case comparison by cause of death
(table 2).
There were 121 cases of stillbirth. In 39 cases (32%) the cause of death was
unknown to the CBS.However, in 36 of these cases sufficient information was
available in the Reinier de Graaf registration and we were able to establish a cause
of death. In the 82 cases in which the CBS had registered a cause of death, it was
consistent in 38 cases (46%) with the cause of death established in our own
research (table 3).
Table 2
Perinatal death:a comparison between registration by the  Central Statistics Office
(CBS) and regional investigation in the region Delft-Westland-Oostland,1983-1992
number of cases according to CBS
registration
number of cases according to
regional registration present absent total
present 198 20 218
absent 29 ? ≥ 29
total 227 ≥ 20 ≥ 247
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As regards first week neonatal mortality, the cause of death registered by the CBS
was consistent with the cause of death established within our own research in 52 of
the 76 cases (68%) (table 3). In the CBS registration there was 1 case (1.3%) of  first
week neonatal mortality in which the cause of death was unknown.
Of the 40 cases in which the CBS used the diagnosis ‘cause of death unknown’
(ICD 7799), 31 cases (78%) could be attributed to anomalies in placenta,umbilical
cord and membranes (ICD 7620-7629) (table 4). In 27 of the 90 cases (30%), the
diagnosis was consistent with the CBS registration; in 32 of the 90 cases (36%) a
different code was used (such as hypertension mother (ICD 7600), hydramnion
(ICD 7613) or multiple pregnancy (ICD 7615)). In 31 of the 90 cases (34%) the code
‘cause of death unknown’ (ICD 7799) was used.
Discussion 
Data pertaining to the numerical reliability of perinatal death within our region are
difficult to obtain.On the one hand the CBS registers perinatal death according to
the mother’s place of residence (through the municipal statistics) thus providing the
region’s mortality rates.On the other hand, the hospital registers at most perinatal
mortality that occurs on the spot.Doornbos et al investigated the numerical
reliability of perinatal mortality in 1981 and 1982 for the Municipality of Amsterdam;
they concluded that there was an under-registration of 14.3% at the CBS.4
In the DWO region (1983 - 1992) at least 20 cases (8.1%) of perinatal death were
not present in the CBS registry.The distinctive features of such cases  included low
birth weight, an amenorrhoea bordering on the official notification requirement and
lethal congenital defects.These characteristics correspond with data from the
literature.4 At the moment, registration of the cause of death totally depends upon
the correct and full completion of the CBS’ B form by the doctor in attendance or
Table 3
Perinatal death rates (%):a comparison between the registration by the Central Statistics
Office (CBS) and regional  investigation (region Delft-Westland-Oostland,1983-1992)
causes of death according to CBS registration and
regional research
similar different total
n % n % n %
stillbirth 38 (46) 44 (54) 82 (100)
first-week mortality 52 (68) 24 (32) 76 (100)
by performing an autopsy.Our study showed a considerable difference in registered
causes of death between own research and in the CBS registration. In 54% of all
cases involving stillbirth and in 32% of the cases involving neonatal mortality, the
cause of death was found to be different. Furthermore the diagnosis ‘cause of death
unknown’ (ICD 7799) was too often used by the CBS,36 out of 82 cases (44%).
Several factors may explain the discrepancies between the registered diagnoses by
the CBS and our study. Firstly, the large percentage of diagnoses ‘cause of death
unknown’ (ICD 7799) at stillbirth may be caused by lack of information to the
doctor completing the B form (usually within hours after delivery or neonatal
death). Support for this hypothesis may be derived from the underregistration of
placental causes for perinatal death, as the result of the placenta examination usually
follows a few weeks after the moment of stillbirth.
Secondly the translation of data recorded on the B form into ICD-9 coding may be
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Table 4
Causes of stillbirth (n=121) and first-week mortality (n=77):according to the Central
Statistics Office (CBS)* and regional  investigation (region Delft-Westland-Oostland,
1983-1992)
number of causes according to CBS number of causes according to
(ICD-9 code) regional research
1 2 3 4 5 6 7 8 9 total
1. congenital anomalies (7400-7599) 39 2 1 2 1 45#
2.disorders of placenta/umbilical cord and
membranes (7620-7629) 1 27 1 4 1 34#
3.birth trauma (intracerebral haemorrhage)
(7670-7679) 1 2 3#
4. intrauterine hypoxia and asphyxia at birth,
and aspiration (7680-7689) (7700-7705) 7 4 11#
5. ’respiratory distress syndrome’ (7690) 1 1 15 1 18#
6. infections specific to perinatal period (7710-7718) 1 1 1 2 5#
7.haemolytic disorder of foetus/newborn child by
iso-immunisation (7730-7735) 1 1#
8.other, including hypertension mother (7600)
and multiple pregnancy (7615) 6 21 1 3 3 1 1 - 5 41#
9.unknown (7799) 31 5 1 3 40#
Total 47 90 5 18 20 6 2 0 10 198#
* According to ‘International classification of diseases 9’
# This concerns 39 cases of stillbirth and 1 case of first-week neonatal mortality
incorrect  or there may be a difference of opinion between the CBS and the region
researchers as to which coding should be used.
Thirdly the setting of the current study guaranteed a maximum effort by the fetal
pathologist,obstetrician and paediatrician to come to a correct diagnosis. In daily
medical practice the diagnosis will often be made under less ideal circumstances.
This multidisciplinary extra effort might decrease the discrepancy between the
clinical registration diagnosis and the CBS registration. It is beyond our scope to say
to what extent the CBS publications with national data on causes of death are being
used for further research.
A thorough and critical review of the procedure for notification and registration of
causes of perinatal death seems warranted. It may be helpful to alter the current
registration method of the CBS so that notification using the A and B form is
followed by a second report approximately 6 weeks after the first registration,when
more will be known about the background of the death. In our opinion the current
ICD-9 registration is insufficient for studying the causes of perinatal mortality, as this
classification system shows overlap and is often too fragmented. Too general
diagnoses, such as ‘hypertension mother’ (ICD 7600), and pregnancy complications,
such as ‘multiple pregnancy’ (ICD 7615) offer no real insight into the causes of
perinatal mortality.
We conclude that registration of the causes of perinatal death is not adequate in its
current form.Given discussion of the fact that the perinatal rate of mortality in the
Netherlands, in the last decade,has decreased less rapidly than in surrounding
countries, it is all the more necessary to use reliable methods of registration for
perinatal mortality.8
We would like to thank M.R.Patijn,Data Specialist of the Central Statistics Office, and Dr. P.J.C. van der
Straaten,Paediatrician, for their contribution to this research.
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Chapter 3
Perinatal mortality in Delft and environs,1983 - 1992: further
decrease possible by specific attention to lethal congenital
anomalies and placental insufficiency
A.E.M.de Galan-Roosen, J.C.Kuijpers, J.P.Mackenbach
Ned Tijdschr Geneeskd 1999 ; 143:152-157
Abstract
Objective:To establish the distribution of perinatal mortality over the various levels
of obstetric care, taking into account the various causes of perinatal mortality.
Design: Prospective,descriptive.
Methods:Data were collected on all parturitions of women living in the region of
Delft-Westland-Oostland (DWO) of the Netherlands,during the period 1983-1992,
regardless of the ultimate setting of the parturition. A prospective regional
registration system for perinatal mortality in the region was matched with the
registration by the Central Statistics Office (CBS).Using anonymous linking,
duplicatures could be excluded. A gynaecologist, a paediatrician and a paediatric
pathologist assessed the causes of death. It was determined for all cases of perinatal
mortality whether the antenatal care had been under the final responsibility of a
midwife or a general practitioner (primary care), either at home or in the hospital,
or under the final responsibility of an obstetrician (secondary care).
Results: In the decade studied,28,983 children were born in the DWO region;51%
under primary care management.The actual perinatal mortality of the region was
calculated as at least 247 cases (0.85%). In 26% (n=64) of these cases, the childbirth
was managed under primary care responsibility, in 43% (n=106) after risk selection
from primary to secondary care, in 14% (n=34) under the exclusive responsibility of
secondary care and in 17% (n=34) after risk selection from secondary to tertiary
care.The most frequent causes of death were progressive placental insufficiency and
lethal congenital anomalies.
Conclusions:The results show that further decrease of perinatal mortality may be
achieved by risk selection (in primary care) with regard to lethal congenital
anomalies and acute or progressive placental abnormalities.The perinatal mortality
is so low (0.85%) that further medicalization of childbirth may be expected to
contribute only little to a further decrease of the perinatal mortality figures.
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Introduction
Obstetric care in the Netherlands differs from surrounding countries with regard to
two conspicuous phenomena,namely home confinement and the relatively low
frequency of assisted delivery.1,2
In the Netherlands it is possible to deliver under primary care at home or in the
hospital in an outpatient setting, under the supervision of a midwife and in some
areas a general practitioner without the involvement of an obstetrician.This is a
unique situation in the civilized western world,which – unlike in the developing
countries – arises from a conscious decision to do so.One may wonder whether
this unique organisation of obstetrics in the Netherlands has consequences for the
quality of the obstetric care provided.This question is raised both nationally and
internationally, and becomes imperative considering the less rapid decrease in
perinatal mortality rates in the Netherlands in comparison to the countries around
us.1,3
The question is whether the current obstetric system, in which pregnant women
who run an increased risk of perinatal mortality are recognized in time and referred
to secondary care in the Netherlands, guarantees adequate risk selection.
In the Netherlands the percentage of home confinement per healthcare area 
(division according to the one used by the Coördinatiecommissie Regionaal
Onderzoeksprogramma (COROP;Co-ordination Committee Regional Research
Programme) widely differs.The highest percentage of home deliveries is observed in
Overijssel and Friesland (both 41%), the lowest percentage is found in Limburg
(26%).2
On average 31% of pregnant women in the Netherlands had a home delivery in
1992,whereas this was still over 68% in 1965.Not only the home deliveries are part
of  primary care,but 33% of the hospital deliveries also occur in an outpatient
setting under the supervision of the midwife or general practitioner. In the
Netherlands, therefore, there are areas where more than half the pregnant women
deliver under the supervision of primary care at home or in an outpatient clinic
(figure 1).4 Our healthcare region Delft-Westland-Oostland (DWO) is such a
region,offering a typical representation of Dutch obstetric care with 51% deliveries
under primary care.
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From 1980 onwards a perspective regional study was set up in the DWO region in
order to obtain a detailed view of the causes of perinatal mortality.The purpose of
the current study was to answer the following questions:what is the division of
perinatal mortality over the different echelons of obstetric care (primary and
secondary care) and does this division differ for the various causes of perinatal
mortality? Is a better risk selection and consequently a reduction in perinatal
mortality feasible?
Data and methods
During 1983 - 1992 a prospective analysis of perinatal mortality was carried out in
the COROP region DWO with approximately 215,500 inhabitants. For the purpose
of this investigation, the DWO was extended to include Nootdorp.The region also
included the Municipalities of Delft, ’s-Gravenzande,De Lier,Maasland,Monster,
Naaldwijk,Pijnacker, Schipluiden and Wateringen.Data pertaining to all deliveries by
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Figure 1
Percentage (a) children born at home by COROP area,1992 (     = 15-25 %), = 26-33 %,
= 34-41 %, = 42-48 %) and (b) children born in primary care under the supervision of a
midwife or general practitioner) by COROP area,1992 (     = 15-30 %, = 31-45 %, = 46-50 %,
=  51-70 %)4.
COROP = Coordination Committee Regional Research Program. = region Delft-Westland-
Oostland (DWO),with 38 % home confinements and 51 % deliveries in primary care.
women residing in the region, regardless of the final place of delivery,were
collected.
In order to obtain a complete view of perinatal death in the region, a number of
registration systems were used.The Reinier de Graaf Gasthuis in Delft is the only
hospital in the region and is situated centrally, so that it attracts a majority of cases
of obstetric care (table 1).Three Reinier de Graaf Gasthuis’ hospital registration
systems were consequently used as the primary source:
1. The local version of the Landelijke Verloskunde Registratie (LVR;Perinatal
Database of the Netherlands);
2. A manually updated registration of ante-partum transfers from the Reinier de
Graaf Gasthuis to hospitals with a neonatal intensive care unit (NICU);
3. A pathology registration system for perinatal autopsies from the region.
Furthermore,data from all transfers of new-born children born in the Reinier de
Graaf Gasthuis, co-ordinated by the Neonatology department of the Academisch
Ziekenhuis Leiden (Leiden University Hospital) were investigated.
In addition to this, the CBS registration was consulted for all deliveries of live-born
children, stillborn children and children who died within 7 days postpartum from the
region, including home deliveries and clinical deliveries that took place outside the
region (source:Population Statistics Department S1 of the CBS). After anonymous
linking with the aid of the child’s date of birth and the mother’s age and place of
residence, these data were compared with the data collected locally.5
Clinical data regarding pregnancy,parturition and puerperium of all cases of
Distribution of perinatal mortality over various levels of obstetric care
31
Table 1
Live-born and perinatally deceased children by responsibility for obstetric care in the
region Delft-Westland-Oostland,1983 - 1992
responsibility for obstetric care live-born perinatally
children deceased children
(%) (%)
primary care home delivery 10,977 (38) 9 (4)
primary care hospital delivery * 3,822 (13) 55 (22)
primary care –> secondary care # 8,765 (30) 106 (43)
originally secondary care ‡ 4,317 (15) 34 (14)
secondary/tertiary care outside the region § 1,082 (4) 43 (17)
total 28,983 (100) 247 (100)
* Including pregnant women with antenatally deceased fetuses who were referred from primary to secondary care
# Transfer at any moment during the pregnancy
‡ At 16 weeks of pregnancy or less under supervision in secondary care
§ Intrauterine/neonatal transfer to a neonatal intensive care unit from primary and secondary care
perinatal death (stillborn ≥ 28 weeks,neonatal death within the first week
postpartum) from the region were recorded in a data file, along with neonatal data.
These data are completed with autopsy results (carried out in 78% of the cases),
histological examination of the placenta and additional laboratory research.
In consultation with gynaecologist and paediatrician on the one hand and paediatric
pathologist on the other, these data were used to establish the most likely cause of
death in each case.Causes of death were classified according to a modified division
after Hovatta et al.5
In all cases, it was ascertained at the time of death whether the perinatal care fell
either under the responsibility of primary care,both at home and in an outpatient
setting,or under the responsibility of secondary or tertiary care. Furthermore, the
moment of transfer of perinatal care from primary to secondary care if any was
determined.
Results
During the 10 year period (1983 - 1992), 28,983 children were born in the DWO
region;38% of the deliveries were home confinements.Thirteen percent of
deliveries in the Reinier de Graaf Gasthuis took place in the hospital in an
outpatient setting, under the supervision of the midwife or the general practitioner
(table 1). Four percent (1082) of the deliveries took place in a different secondary
or tertiary care hospital outside the DWO region.This included 65 intrauterine
transfers to a tertiary care hospital.
During those 10 years 247 cases of perinatal death were registered.The perinatal
mortality rate of the DWO region over that period amounted to 8.5/1000. In 64
cases (26%) of perinatal death,perinatal care was in the hands of primary care
providers during the entire pregnancy,whereas in 106 cases (43%) death occurred
after referral to secondary care at any moment during  pregnancy or parturition
(table 1). Fourteen percent of all women whose child died perinatally were under
the supervision of primary care from the beginning of the pregnancy. Ten children
were transferred before and and 33 children after birth, from secondary care to
tertiary care, after which the child died in tertiary care. In 13 of these cases the
referral from primary care took place during parturition, so that secondary care was
limited to the few hours that preceded referral to tertiary care.
Anonymization of CBS data, necessary to ensure privacy,prevented  us to establish
the precise moment of transferral from primary tot secondary care in 34% of the
cases.
In the other 66%, there proved to be an equal division between early (> 1 month
prior to birth), average (a few weeks up to 1 day prior to birth) and late referral
Chapter 3
32
Distribution of perinatal mortality over various levels of obstetric care
33
Table 2
Perinatal mortality in the region Delft-Westland-Oostland by moment of transfer to
secondary care (n =106),1983 – 1992
moment of transfer stillborn first-week neonatal total
from primary to secondary care mortality n    (%)
unknown 22 14 36   (34)
> 1 month prior to parturition 18 5 23   (22)
< 1 month and >1 day prior to parturition 15 10 25   (24)
< 1 day and during labour 9 13 22   (20)
total 64 42 106 (100)
Figure 2 
Menstrual age at transfer (in weeks)
Moment of transfer from obstetrical primary care to secondary care of children born in the Reinier de
Graaf Gasthuis: cumulative percentages:
(A) perinatally deceased children and (B) live-born children who survive
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(< 1 day prior to birth) of perinatally deceased children (table 2). Figure 2 shows the
moment of referral to secondary care for live-born children (who survive) and
perinatally deceased children.Mothers of perinatally deceased children came under
the supervision of secondary care providers at an earlier menstrual age than
mothers of live-born children, a sign of risk selection by primary care.
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Table 3
Responsibility for obstetric care regarding perinatally deceased children in the region
Delft-Westland-Oostland,by cause of death,1983 – 1992
main group responsibility for obstetric care
causes of death5
primary primary–> originally secondary–> total
care* secondary secondary tertiary care
care care
asphyxia 6 7 4 5 22
placental haemorrhage/umbilical
cord complication 3 3 2 2 10
abruptio placentae 14 8 6 1 29
placental insufficiency 26 30 12 1 69
congenital anomaly 6 36 3 11 56
sepsis - 2 1 3 6
immaturity 3 6 2 14 25
cerebral haemorrhage 1 - - 4 5
rhesus antagonism/erythroblastosis foetalis - 1 - 1 2
unknown - 9 2 1 12
information unavailable 5 4 2 - 11
total (%) 64 (26) 106 (43) 34 (14) 43 (17) 247
* at home or in an outpatient setting
Table 3 shows that the main cause of death  was progressive placental insufficiency,
which accounted for 41% (26/64) of stillborn children within primary care and 30%
(42/140) within secondary care.These cases of placental insufficiency are specified in
table 4. In both groups villitis was found in approximately one third of all cases. In 4
and 2 cases respectively, a cytomegalo virus and a rubella virus infection was
determined as the cause of the villitis, but the pathogen remained unknown in 16
cases. In addition, circulatory disorders on the maternal side of the placenta and
extensive infarction of the placenta constituted the cause of progressive placental
insufficiency in approximately half the cases.
Nine children from a total of 10,997 parturitions (0.8 per thousand) died during
home confinements, in which 3 cases could be considered genuine death during
labour,namely 1 case of umbilical cord complication and 2 cases of perinatal
asphyxia (table 3). In secondary care there were 16 cases of acute death during
labour from a total of 13,082 (1.3 per thousand), namely 11 cases of acute asphyxia
and 5 cases of umbilical cord complications (table 3).The causes of death of the
newborn children after transferral to a NICU reflect the transferral policy from
secondary to tertiary care,because very young newborn children with serious
respiratory problems, requiring prolonged artificial respiration, and newborn
children with serious multiple congenital anomalies are preferentially transferred to
the NICU.
Discussion
When drawing conclusions from registries for perinatal mortality it is of utmost
importance to take into account the quality and completeness of the database.3,6,7
In this study we made a maximum effort to achieve completeness of the data
collected. 6 If risk selection by primary care is perfect, all cases of perinatal death
should, in theory,occur in secondary or tertiary care.
Twenty percent of the causes of perinatal death in our region were due to lethal
congenital anomalies (56/247; table 3). Apparently, the early detection of children
with serious (lethal) congenital anomalies is quite effective since 39 of the 45 cases
of lethal congenital anomalies were referred to secondary care antenatally before
perinatal mortality occurred.This detection took place with the aid of ultrasonic
diagnostics, partly carried out as routine,but also because of perceived
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Table 4
Causes of chronic placental insufficiency
(region of Delft-Westland–Oostland),1983 - 1992
diagnosis* mortality rate (%)
primary care secondary care
(n = 26) % (n = 43) %
maternal circulation disorder/
fibrin depositions in placenta 5 (19) 8 (19)
placental infarction > 10% 12 (46) 16 (38)
villitis 8 (31) 14 (33)
chorio-amnionitis 2 (8) 3 (7)
unknown 3 (12) 9 (21)
* per perinatally deceased child,more than one cause of placental insufficiency was possible at the same time
abnormalities in fetal growth.Whether timely detection (< 20 weeks of gestation) of
lethal congenital anomalies leads to a decrease in numbers of perinatal death by
inducing labour prior to  the 24th week of amenorrhoea,has not been sufficiently
researched in our region,but seems likely.8
The most common cause of death within the DWO region was progressive
placental insufficiency,with 41% (26/64) of perinatal mortality within primary care
and 30% (42/140) within secondary care,of which more than one fourth (26%) were
referred relatively shortly before parturition (< 1 month) from primary care to
secondary care (not shown in the results). In light of possible prevention or timely
detection of progressive placental insufficiency, it is important to know that a
possibly infectious cause (like villitis) was found in 32% of all cases and circulation
disorders with extensive infarction of the placenta’s cotyledons was found in 40%.
Does the even distribution of these common causes of death over primary and
secondary care indicate that both midwives and gynaecologists have trouble
detecting and treating these diagnoses in time?
The clinicians lack useful risk indicators for predicting placental failure in large
groups of pregnancies at low risk.Hopefully a screening test will be available in the
near future, that can offer a reliable predictive value for the functioning of the feto-
placental unit in otherwise uneventful pregnancies.This may include determining
relevant infectious diseases or disturbances in the blood coagulation.9
The abruptio placentae should be regarded as a suddenly occurring event that
usually occurs  infrequently in healthy pregnant women.Primary risk selection in
advance proves to be difficult. In our investigation,14 cases occurred in primary
care,whereas 8 cases were transferred to secondary care.The share of primary care
in neonatal mortality within our region may be considered small (13%;8/64),
especially if the causes of death are also taken into account during assessment.
Another important conclusion is that death during labour is a relatively rare
phenomenon in our region,with 25 cases during the 10 years study (25/28,983;0.9
per thousand), 3 cases of which occurred at home.Transferring the home
confinement to the hospital will therefore offer little or no improvement in this
area. Furthermore, a strong increase in the number of medical interventions
surrounding the parturition (including caesareans) will only have a marginal
influence on the total perinatal mortality.
Even after correction for under-registration,6 perinatal mortality within our DWO
region remains below the national average (0.93%) at 0.85% and corresponds with
the rate in the countries around us.10,11 A great deal of obstetric care takes place in
primary care:81% of the pregnant women start the antenatal check-ups in primary
care and 51% of all deliveries are fully completed under the supervision of primary
care.The contribution of primary care to perinatal death amounted to 26%.
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However, it should be noted that 43% of the pregnant women experiencing
perinatal death were transferred at any moment during  pregnancy from the
responsibility of primary care to secondary care (table 2 and figure 2).The
secondary care’s share in perinatal mortality probably came about by risk selection,
so that perinatal mortality within the referred group amounted to 13 per thousand
of the total number of children born in the DWO region, as opposed to 4 per
thousand of the total number of children born under the responsibility of primary
care providers.
Conclusion
Based on the results presented from the region DWO, prevention of perinatal
mortality should not be achieved by a shift from primary to secondary care,but
rather in different forms of co-operation between primary and secondary/tertiary
care.The focus should be on the timely detection of serious congenital anomalies in
the foetus prior to 20 weeks of pregnancy and on developing clinically useful devices
for detecting progressive placental insufficiency.
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Part 1I
C L A S S I F I C AT I O N  O F  C A U S E S  O F
D E AT H
Introductory remarks
Chapter 4 was written in 1998 and describes the incidence of all congenital
malformations in 247 cases of perinatal death. In this study the perinatal mortality
according to the CBS definition before July 1991 was used.Fifty cases with lethal
congenital malformations were described.
The second and third studies of this part were accomplished between 1999 and
2001. As the WHO recommended in the 10th revision of the International
Classification of Diseases (ICD-10) to use for perinatal mortality the period
commencing at 22 completed weeks of gestation (the time birthweight is normally
about 500 grams) and ending within 7 days postnatally,we have used this definition
as well.Both studies were published in an international journal. 239 cases of
perinatal mortality with a birthweight of 500 grams or more could be included into
the studies.
Chapter 5 describes a validation of a classification system proposed by the authors
(AG, JK,PS). Six independent assessors (2 paediatricians, 4 gynaecologists) classified
all cases of perinatal death and were not involved in the original development of the
classification system.
Chapter 6 describes the evaluation of 239 cases of perinatal death using the newly
introduced classification system.This study was performed by the authors who
developed the classification system (AG, JK,PS).
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Chapter 4
Contribution of congenital malformations to perinatal
mortality. A 10 years prospective regional study in
the Netherlands
A.E.M.de Galan-Roosen, J.C.Kuijpers,A.P.J.Meershoek,D.van Velzen 
Eur J Obstet Gynecol Reprod Biol 1998 ; 80:55-61
Abstract
Objective:To determine the contribution of congenital malformations to perinatal
mortality in a region.
Design:Prospective,descriptive.
Setting: Region,Delft-Westland-Oostland (DWO) in the Netherlands.
Material and methods:The registration was based on data concerning all deliveries of
women domiciled in the health region DWO in the Netherlands.The incidence and
contribution of congenital malformations to perinatal death was evaluated by a team
consisting of a gynaecologist, a paediatrician and a paediatric pathologist.
Malformations were classified as lethal,or non-lethal and recorded separately for
stillbirth (from 28 weeks of gestation) and live born children who died within 7 days
postnatally.
Results: In 10 years (1983-1992) 28,983 children were born in the region DWO.The
perinatal mortality was calculated as 247 cases (0.85%).The overall incidence of
congenital malformations in the perinatal death-group was 33%.Lethal congenital
malformations were found in 51% of the cases in the stillbirth-group and 70% of the
cases in the neonatal death-group.Congenital malformations of the central nervous
system are mostly lethal in the stillbirth-group (45%).Cardiovascular- and
pulmonary defects were more prominent in the neonatal period (27% and 33%
respectively of the neonatal deaths).Uro-genital and minor malformations
(miscellaneous) are more often seen in perinatal deaths without being a contributor
to the cause of death.
Conclusions:As most congenital malformations are multi-factorial in origin, it is in the
understanding and control of such conditions that efforts and resources should now
be turned.Through a detailed fetal postmortem,placental examination and clinical-
pathological correlations, lethal congenital malformations were found in 51% in
stillbirths (mainly central nervous system) and 70% in neonates (mainly
cardiovascular- and pulmonary defects).
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Introduction
The past decades have shown a strong decline in perinatal mortality in the
industrialised western world.This is mainly a result of a decline in perinatal deaths
due to prematurity and infectious diseases.1 In contrast published rates of perinatal
death due to congenital malformations have not declined substantially.They have
therefore become relatively more important and nowadays account for 20 to 25%
of the perinatal deaths in the western world.2-4 However, this figure conceals
important differences between stillbirths and early neonatal deaths. Although
stillbirth and neonatal mortality rates have decreased to similar extents during the
last fifty years, congenital malformations,which were almost equally frequent causes
of death in both of them at the beginning of this period, are now about twice as
common in early neonatal deaths (< 1st week) as in stillbirths.1
Apart from mortality, congenital malformations result in considerable morbidity.
Depending on the classification criteria, 1 to 3% of all births are associated with a
major congenital malformation,many of which have long-lasting effects.5,6
As a result of the above, and with an aim at prevention and/or treatment, interest in
the pathogenesis of developmental abnormalities has increased. A wide range of
factors are presumed to play a role in the aetiology of congenital malformations,
each with varying potential for preventive intervention.Genetic factors contribute
to as much as 30% of all cases with anomalies,whereas environmental factors may
contribute in as little as 6%.Thus in over 60% of all cases a multifactorial or at least
unknown factor is operative.6,7
Present registration systems,whether on regional (Eurocat-workinggroup)5 or
national base (National Bureau for Population Statistics of the Netherlands,CBS) all
are based on voluntary registration with varying compliance.
In addition they offer a limited level of detail, usually not allowing for the analysis of
the precise role of the malformation abnormality in causing death.Because of the
above continued basic and population epidemiological research is required if we are
to gain a better understanding of the causes of congenital malformations and the
pathogenetic processes involved.
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Materials and methods
Region
The Dutch Delft-Westland-Oostland (DWO) healthregion, a semi-industrialized
agricultural region,had a stable population of just over 215,500 inhabitants for the
whole of the study period and a stable birthrate resulting in 28,983 still- and live
born infants during the study decade (1983-1992).
Based on the specific characteristics of obstetrical care in the Netherlands,
approximately 51% of the deliveries either took place at home or in an outpatient
setting. All pathology is directly managed at clinical level, resulting in complete
registration.The registration was based on data concerning all deliveries of women
domiciled in the region, irrespective of the ultimate place of delivery,during 1983-
1992.By linking, in retrospect, a prospective regional registration system for
perinatal mortality within the region anonymously to the registration of the Central
Statistics Office of the Netherlands (CBS), the reliability of the latter registration
with regard to the causes of death was determined.To establish the causes of death,
all available data were judged by a team consisting of a gynaecologist, a paediatrician
and fetal pathologist.8
Patientgroups & Data collection
Included in a total of 14.164 clinical high-risk patient deliveries a total of 189 cases of
perinatal death were recorded.Of the high-risk pregnancies 42 cases of perinatal
death took place in a level 3 hospital after preterm delivery or neonatal transfers.
Of the 14,819 low-risk patient deliveries 58 perinatal death cases were registered of
whom 9 children died at home.
As all deliveries (live- and stillborn) are registered by the Central Statistics Office of
the Netherlands (CBS), 29 cases initially lost for follow up were found again by
anonymously contacting the doctors who signed the death-certificates.Of these
cases there were 5 children who died neonatally of unknown congenital
malformations, they were included into the study.
Patients were divided into two different categories:
• Stillbirth/ intrapartum death, all cases of intra-uterine death from 28 weeks of
gestation, including children who died within 30 minutes postnatally.
• Neonatal death, live born children from 24 weeks gestational age,who died within
7 days postnatally.
A total number of 247 cases of perinatal death were recorded,of which 82 cases
were associated with congenital malformations and included into the study.
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Autopsy
All postmortems,both fetal and neonatal,were carried out according to the same
protocol,which includes:
• Full X-ray analysis, registration of all relevant physical dimensions against tables for
standards for gestational age.
• Macroscopical examination of all organ-systems including neuro-pathological
examination, registration of all (minor and major) congenital malformations,
bacteriological and virological cultures of all orifices, blood and urine,maternal
TORCH (Toxoplasmosis,Rubella,Cytomegalo,Herpes )-serology and routine
standardized histology of all organs and organ systems.
Placental examination
All postmortems included a standardized placental examination according to recent
data in literature.9,10
In addition to a macroscopic examination of shape, type and weight of the placenta,
full standardized microscopic examination was performed with special interest in
detection of signs of infection (chorio-amnionitis, villitis), ischaemia, trophoblastic
proliferation, and intra-placental coagulopathy.
Genetic studies
In all cases with two or more congenital abnormalities or with suspicion of genetic
abnormalities on other grounds (prenatal ultra-sound,dysmorphic signs), genetic
studies were carried out either by lymphocyte or skin fibroblast cultures by the
Regional Cytogenetic Reference Laboratory (KGCL Rotterdam, the Netherlands).
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Results
The distribution of perinatal mortality cases is shown in table 1. In 25% of the
children in the stillbirth-group and 47% of the children in the neonatal death-group
at least one congenital malformation was found at autopsy.
The congenital malformations were classified as lethal in 51% of the cases in the
stillbirth-group and in 70% of the cases in the  neonatal death-group (table 2). In
those cases of non-lethal congenital malformation, the cause of death for the
stillbirth-group showed a considerable number of progressive placental insufficiency
(33%) or placental and/or cord pathology (8%) (table 2).
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Table 2
Most probable causes of perinatal mortality in combination with congenital
malformations:region DWO 1983-1992
Causes Stillbirth Neonatal death
(N) % (N) %
1  Lethal congenital malformation 20 51 30 70
2  Abruptio placentae 2 5.5 - -
3  Placental bleeding/cord problems 1 2.5 - -
4  Acute asphyxia 2 5.5 1 2.3
5  Progressive placental insufficiency
based upon:
Maternal circulatory disorders 3 7.5 - -
Infarction 4 10.5 - -
Villitis 5 12.5 - -
Villous disorders and unknown disorders 1 2.5 - -
6  Cerebral haemorrhage 1 2.5 1 2.3
7  Sepsis neonatorum - - 1 2.3
8  Immaturity - - 3 7.0
9  Unknown+lost for follow-up - - 7 16.1
Total 39 100 43 100
Table 1
Perinatal mortality and congenital malformations:region DWO 1983-1992
Total With congenital malformations
(N) Major Minor %
Stillbirth (≥ 28 weeks) and
intrapartum death 155 20 19 25
Neonatal death (<7 days) 92 30 13 47
Total 247 50 32 33
The lethal congenital malformations are summarized in table 3. As can be expected,
cardiovascular defects and pulmonary defects were more prominent in the neonatal
period than during pregnancy.Cardiovascular defects accounted for 27% and
pulmonary defects for 33% of the neonatal-deaths.
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Table 3
Lethal congenital malformations:region DWO 1983-1992
Stillbirth Neonatal death
(N) % (N) %
Cardiovascular 1 5 8 27
Hypoplastic left heart 1 3
AV-canal - 1
Dysplasia aortic/mitralic valve - 2
Right ventricle outflow tract obstruction - 1
ASD and VSDb - 1 
Pulmonary 3 15 10 33
Congenital lunghypoplasia
Unknown origin 2 0
Or based upon:
Potter’s sequencee - 4
Thanatophoric dwarfism 1 1
Diaphragm herniationc - 4
Turner’s syndromed - 1
Central nervous system 9 45 7 23.3
Anencephaly 8 4
Encephalocele 1 -
Myelomeningocele/hydrocephaly - 3
Uro-genital 3 15 - 0
Adrenal agenesis 1 -
Renal agenesis in VACTERL and
Meckel-Gruber syndrome 2 -
Gastro-intestinal 1 5 1 3.3
Cavernous haemangioma liver 1 -
Gastro-schizis - 1
Chromosomala.d. 3 15 3 10
Triploidy 69 XXX 2 -
Trisomia 13 1 1
Trisomia 18 - 2
Inborn metabolic diseases
Urea cycle disorder - 0 1 3.3
Total 20 100 30 100
a
Two cases of trisomia 21 were registered, the cause of death were a corvitium 
b
and a diaphragm herniation 
c
d
In one case of Turner’s syndrome the cause of death was lung hypoplasia.
e
One  VACTERL association with lung hypoplasia.
Only one case of intra-uterine death is noted caused by a hypoplastic left heart.
Congenital lung hypoplasia appeared to be lethal in the neonatal period when it was
associated with an extended diaphragm herniation4 and in a Potter’s sequence.4Two
cases of thanatophoric dysplasia with cloverleaf skull were noted also associated
with lung hypoplasia.
In contrast with the cardiovascular/pulmonary defects, congenital malformations of
the central nervous system are the most important group of lethal-congenital
malformations (45%) in the stillbirthgroup.The prevalence in our study of
anencephaly and myelo-meningocele is 0.41, respectively 0.21 per 1000 births.
We registered 7 lethal uro-genital malformations (adrenal agenesis/renal agenesis)
of whom 4 with Potter’s sequence died of severe lung hypoplasia. In case of gastro-
intestinal malformation one died intra-uterine caused by an extended cavernous
haemangioma of the right liver-lobe (diameter of 10 cm),which caused cardiac
decompensation and asphyxia.The other died neonatally of severe gastro-schizis.
Chromosomal defects are found in 10 out of 50 perinatal deaths caused by
congenital malformations (20%).There were three cases of trisomia 21 in the
neonatal death-group, these children died of a diaphragm herniation, corvitium and
in one case it was unknown. In one case of Turner’s syndrome the baby died
neonatally of lunghypoplasia.
Four complex syndromes were recognized; in Meckel-Gruber syndrome there is
also a severe lung hypoplasia caused by the bilateral renal agenesis, in combination
with an encephalocele. In the VACTERL (vertebral, anal, cardiac, tracheo-
oesophageal, renal, limb-deformities) syndromes a scale of urogenital malformations
is found. In Fryn’s syndrome a diaphragm herniation caused lung hypoplasia.One
inborn error of metabolism is recognized as a cause of neonatal death,with
disorders in the urea cycle causing hyper-ammonaemia and high levels of the amino-
acids lysine,ornithine and glutamine. A specific type of enzyme-deficiency could not
be identified.
Studying perinatal causes of death,not only lethal congenital malformations,but also
other (minor) congenital malformations are worth knowing. Summarizing all
congenital malformations (lethal and non-lethal; see table 4),we find 280 structural
abnormalities in 82 cases of perinatal death.Of the total of 280 structural
abnormalities, 98 of these are part of a wide range, the remaining 180 belong to one
of the 6 main categories.
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From the comparison of table 3 and 4 we can conclude that urogenital
malformations and minor malformations (miscellaneous) are more often seen in
perinatal death without being a contributor to the cause of death. Studying the
minor congenital malformations (table 5), 11 cases of agenesis of parts or whole
organs,were recorded with skeletal defects. In 2 cases of  VACTERL association
agenesis of parts of limbs,hemi-agenesis of the uterus, renal agenesis, a cardiac
defect and lung hypoplasia were found as associated anomalies.
Absence of an umbilical artery occurred in 9 cases and in 4 of these it was the only
congenital malformation found. In 1 case of single umbilical artery a combination
with severe gastroschizis was found. In another 4 cases it was seen with multiple
congenital malformations like anencephaly, lung hypoplasia, diaphragm herniation,
omphalocele, renal agenesia/dysplasia and corvitium.
There is a large group of dysmorphic/hypoplastic features, in some cases they are
recognized as expressing a known syndrome such as DiGeorge anomaly with
thymus (hemi)-agenesis and hypoplastic/absent parathyroid gland. A Hygroma colli
cysticum was seen in combination with a larynx malformation in a Turner
phenotype.
Minor shape defects contained e.g. hyperlobulation of the lung,wide spaced nipples
and low set ears.
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Table 4
Major and minor congenital malformations:region DWO 1983-1992
Classifications Stillbirtha Neonatal deathb
(N) % (N) %
Cardiovascular 20 16.00 39 26.00
Pulmonary 8 6.25 14 9.00
Central nervous system 21 16.00 18 12.00
Uro-genital 16 12.50 19 13.00
Gastro-intestinal 9 7.00 9 6.00
Chromosomal 3 2.25 6 4.00
Miscellaneous 52 40.00 46 30.00
Total 129 100 151 100
a
N=39 children;
b
N=43 children
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Table 5
Miscellaneous congenital malformations:region DWO 1983-1992
Stillbirth Neonatal death
Agenesis malformations
Costa 4 1 1
Costa 12 1 -
Hemivertebrum th.4 - 2
Right hand 1 -
Right arm 1 -
Right leg 1 -
Ray 4/5 left foot - 1
Radius - 1
Sacrum - 1
a.umbilicalis 7 2
Glandula parathyreoidea 1 -
Left adrenal gland 2 -
Right testis 1 -
Hemiagenesis right uterus - 1
Dysmorphic/hypoplastic signs
Thymus dysmorphia/hemiagenesis 4 3
Anomalia a. vertebralis 1 -
a. lusoria 4 -
(Kypho)scoliosis 2 1
Thanatophoric dysplasia with cloverleaf skull 1 1
Hypoplasia ray I left hand 1 -
Hypoplasia left leg - 1
Hypoplasia costa/thoracic wall defect - 1
Hip dysplasia - 1
Poly/syndactyly 2 2
Talipes equinovarus 1 1
Malformation os occipitalis 1 1
Larynx malformation - 1
Cleft lip and cleft palate 1 2
Intrahepatic gallbladder 2 -
Meckel’s diverticulum 3 3
Inguinal herniation - 1
Hygroma colli cysticum - 1
Microphtalmos - 1
Hypertelorism 1 -
Adrenal hypoplasia 1 3
Teratoma os coccygis - 1
Minor shape defects 11 11
Inborn metabolic disease
Urea cycle disorders - 1
Total 52 46
Discussion
The high occurrence (35%) in our population of cardiovascular and pulmonary
malformations of a specific type in the neonatal period is explained by and
underscores the independence of life in utero of lungs, pulmonary perfusion and the
compensatory function of the Botallian duct in pathology of the left heart. As a
uniquely high rate in our region is improbable (although the total numbers are
limited) a considerable degree of under registration in historical studies seems the
most probable explanation.Machin3 found 18% cardiovascular and pulmonary
malformations and Cornel5 0.64% in still- and lifeborn children.
In our material pulmonary hypoplasia occurs relatively frequent.Two cases of
congenital lung hypoplasia are classified in the stillborn group because these children
died within minutes after birth as pulmonary ventilation appeared impossible. In
another 2 cases pulmonary hypoplasia is associated with potentially lethal skeletal
abnormalities such as a thanatophoric dysplasia.The prognosis of lung hypoplasia at
term (seen in 5 cases) is limited especially when associated with abnormalities of the
urinary tract i.e. in oligohydramnion seen in combination with  Potter’s sequence or
urinary tract obstruction.22
Diaphragm herniation, seen in 4 cases, includes gross reduction in size of the ipsi-
lateral lung, the contra-lateral lung shows a varying degree of hypoplasia as well.16
Because diaphragmatic herniation is increasingly recognized prenatally in utero,
physicians need to be aware of the high risk (in excess of 40%) of associated
chromosomal anomalies and other syndromes.17There was one case of Fryn’s
syndrome (autosomal recessive)  which is an excellent example of this association.
In antenatal ultrasound, certain recognition of all, even severe cases of pulmonary
hypoplasia is still not possible.14 At present the recognition of oligohydramnios only
indicates the possibility of pulmonary hypoplasia,without predicting  the degree of
severity.The chromosomal abnormalities recognized in this population (4.1%) show
a relatively small contribution of this kind of pathology on a population base.The
contribution of chromosomal abnormalities is considered to vary from 40-60% in
second trimester abortions, from 5-10% in the stillbirth group and from 0-5% in live
births.11,15
Abnormalities of the central nervous system were more often seen as lethal
congenital malformations in the stillbirth group.Curry stated that the incidence of
neural tube defects is significantly higher in embryos and stillborns (about 1:1000)
than in livebirths and the cause is heterogeneous,with both genetic and
environmental factors being implicated.17 In literature encephaloceles are usually
sporadic,15 in our material it was seen in one case of Meckel syndrome with renal
agenesis and lung hypoplasia.Holoprosencephaly with abnormal cleavage of the ce-
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rebral hemispheres is not uncommon and has been seen in chromosomal
abnormalities like trisomia 13 and 18 .17 In our study it was seen in a case of
trisomia 13.
From clinical observations it is known that intra-uterine growth retardation
(IUGR)18,24 and multiple pregnancies19,20 are more often seen associated with
perinatal death and congenital malformations than normal growth singletons.
In our study the percentage of IUGR (defined as a birth weight under the 2.3
percentile according to Kloosterman)21 appeared to be (35/77) 46 in the malformed
fetuses of the perinatal death group.There were 5 twin pregnancies (3 bichorials and
2 monochorials): all had smaller dysmorphic signs like a tube-shaped bladder and
inguinal herniation,none of them died of a major congenital malformation.The
higher rate of major congenital abnormality found in twins is largely contributed by
monozygotic twins.20,23
The relatively large group of miscellaneous conditions in our material was usually
associated with one or more abnormalities within the major categories. As such,
although less relevant to prognosis, they may function as warning signals for known
syndromal associations.The correct recognition of these syndromes is important in
order to advise the parents of any possible risk of recurrence and determine the
necessity of and method of prenatal screening.
Further decline in perinatal mortality may be difficult to achieve unless substantial
progress is made in reducing the number of perinatal deaths due to congenital
malformations. A Finnish study showed that detection of major anomalies in an
ultrasound screening program resulted in a decrease in perinatal mortality in
singletons by nearly 50%.13
In a retrospective assessment of a prenatal ultrasound screening program for
detection of anatomical abnormalities performed in the Netherlands, it was found
that in nearly 50% of the screened pregnant women, the anomaly had not been
diagnosed prenatally.12 A recent study in the U.S. showed that ultrasonographic
screening for 15,530 low-risk pregnancies had no significant impact on the
frequency of abortion for fetal anomalies. Survival rates for anomalous fetuses were
also unaffected by screening.25 A significant ultrasound screening program in the
Netherlands is doubtful for deceasing the perinatal mortality rate, although in our
study there were 37,potentially detectable malformations by ultrasound,who
appeared to be lethal in the perinatal period. It could have given a decrease in
perinatal mortality of 15%.
As most congenital malformations are multi-factorial in origin, it is in the
understanding and control of such conditions that efforts and resources should now
be turned.Dietary components like folic-acid have been postulated to play a role in
prevention of neural-tube defects.7
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We cannot emphasize too strongly how important complete and detailed
postmortem fetal and placental examinations and clinicopathological correlation are
to the understanding of the causes of perinatal death also in relation to congenital
malformations.The paediatric pathologist can provide information to differentiate
between developmental abnormalities of similar appearances but quite different
aetiologies and therefore with different prognostic implications.
Congenital malformations have proved to be a recalcitrant cause of infant death and
disability. As most other neonatal problems have gradually abated during this
century, the relative impact of congenital malformations has continued to grow. Any
meaningful attempt to reduce the infant mortality rate further will have to address
the still unresolved causes of congenital malformations.
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Chapter 5
Fundamental classification of perinatal death
Validation of a new classification system of perinatal death
A.E.M.de Galan-Roosen, J.C.Kuijpers,P.J.C. van der Straaten, J.M.W.M.Merkus 
Eur J Obstet Gynecol Reprod Biol 2002, vol.103/1
Abstract
Objective:To validate a newly introduced classification system for the registration of
perinatal mortality.
Design:Descriptive.
Setting: Dutch healthcare region Delft-Westland-Oostland (DWO).
Material and methods: In a 10 years period (1983-1992) all cases of perinatal death
with a birthweight of 500 grams or more  (n=239) were included into the study. Six
assessors: 4 gynaecologists and 2 paediatricians were asked to classify all cases
using a classification model proposed by the authors.This model is based on the
underlying cause of death using simple principles of obstetrical and neonatal
pathology:birth trauma, infection,placenta or cord pathology,pathology of immune-
tolerance of mother and  fetus, congenital malformation of the fetus and
complications of a pre-viable delivery.Therefore we used the term fundamental
classification.The 6 assessors worked independently of each other in classifying all
cases of perinatal death,were not involved in the original development of the
system and were unaware of the results of the classification of their colleagues.
Agreement beyond chance between assessors was calculated using Kappa’s
coefficient for multiple observers and multiple test results.
Results: Overall kappa was 0.70 (95% Confidence Interval 0.68-0.72).
Reproduciblility was poor for the categories trauma and unclassifiable, fair for the
categories infections and placental/cord pathology, and very good to excellent for
the categories maternal immune system pathology, congenital malformations and
complications of prematurity.
Conclusions:The proposed  system showed a good level of agreement and appeared
to be simply applicable. It offers a good insight in the underlying cause of death with
the possibility for recognising preventive factors in future pregnancies and will
enable (inter)national comparisons in causes of perinatal death. A reliable uniform
registration of perinatal death based on the underlying causes should be the basis
for improvement of the quality of perinatal care.
Keywords
Classification of perinatal mortality, underlying cause of death, goal of a classification
system perinatal audit, agreement, reproducibility, quality of perinatal care.
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Introduction
Perinatal mortality figures including stillbirths and the first-week neonatal 
deaths are used as a measure of the quality of perinatal care.Comparison of
perinatal mortality figures however is hampered by several problems:
First of all, there is a problem in the definition of perinatal mortality (including fetal
death, live birth and neonatal death). For example, the World Health Organisation
(WHO)  recommended in 1977:‘For international statistics the term perinatal
death should include early neonatal deaths (7 days postnatally) together with those
fetal deaths of weight 1000 grams or more,or if weight is unknown a gestational age
of 28 weeks or more,or a crown-rump-length of 35 cm or more’.1
Many countries however use definitions different from these WHO
recommendations. In 1992 the WHO introduced  the 10th revision of the
International Classification of Diseases which defines for perinatal mortality the
period commencing at 22 completed weeks of gestation (the time when birthweight
is normally 500 grams) and ending within 7 days postnatally.2 As today many
neonates born before 28 weeks survive, the use of different definitions leads to
incomparable perinatal mortality figures.3,4
Secondly there is  a problem of considerable differences in registration reliability
(mainly underregistration) of perinatal death between and within countries.5-7
Registration and classification of perinatal death may bring to light that some causes
of perinatal mortality in some areas are rarely seen or registered.Furthermore
registration of causes of perinatal mortality may offer the possibility to look for
preventive measures in the future and to give a better preconceptional advice.
Therefore a reliable classification system makes registration of perinatal mortality
more worthwhile. A new easy to use classification model is validated in this study.
History of classification models
Classifying causes of perinatal death was first proposed by Baird et al.8 using the
Aberdeen Clinicopathological Classification. Since then several classification systems
were introduced varying with the specialty of the individuals who developed them.
None of the currently available published methods of classifying perinatal deaths
however, takes into account the full sequence of prenatal, intra-partum and
postpartum events that finally resulted into death.
The Aberdeen Clinicopathological Classification8 was almost entirely based upon
clinical information because in their experience postmortem examinations failed to
explain the cause of death in over 40% of the cases.However using their system still
33% of the causes of death remained unknown.
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In 1958 Butler & Bonham developed  a fetal and neonatal classification based upon
the British Perinatal Mortality Survey (BPMS) including post-mortem findings.9 The
meaning of clinical factors was limited in this classification system.
In 1977 Naeye classified causes of  fetal death not only according to fetal pathology
but to placental pathology as well.10The system is descriptive,with little or no
explanation for the causal mechanism of death.
Wigglesworth proposed in 1980 a system for classifying perinatal deaths.He
purports to  be relatively accurate with this classification system,even in the
absence of a postmortem examination. A comparison of various studies using the
Wigglesworth classification however shows  21- 41% of unexplained (classified as
normally formed macerated) fetal deaths.11,12The classification system is simple. In a
study attempting to validate the Wigglesworth classification, the percentage
agreement appeared to be 85%.13 Later an improved six point fetal and neonatal
system (New Wigglesworth) was proposed by Settatree14 and showed slightly more
agreement (86.8% in a panel). Practical use however is limited as several used
categories in this classification model were too aspecific.
Autio-Harmainen and co-workers (1983) developed a classification system for
neonatal death in which a difference between immediate cause and underlying cause
of death was made.15
In the same year Hovatta produced a classification system for stillbirth. Using
necropsy findings only 57% of the cases could be explained,but also taking clinical
findings into account,91% could be classified.16
Modified versions of the Aberdeen Classification17 and the BPMS18 were introduced
in 1986 with the purpose of subclassification of perinatal causes of death.
In 1986 Hey et al. recommended to use the International Classification of Diseases
code (ICD-9), for each main factor contributing to death. In the Netherlands the
Central Statistics Office (Centraal Bureau voor de Statistiek,CBS) uses the ICD-9
as well, but this classification appears to be unsuitable for the study of the
backgrounds of perinatal mortality.7
In the same year Whitfield19 proposed a classification of Total Perinatal Related
Wastage (TPRW) combining the obstetric classification  of the Aberdeen
Classification and the pathological classification of the BPMS including late
abortions, late neonatal deaths and infant deaths.However, the causal mechanism
behind several applied categories remains unclear using this classification system.
In 1989 Georgsdottir et al.20 proposed ‘the extended Aberdeen classification’.This
model had only minor modifications:Only the categories ‘premature’ and ’mature
cause unknown’ were changed into ‘low birthweight cause unknown’ and ‘normal
birthweight’.
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The most recently published classification system (1996), the Nordic-Baltic perinatal
death classification system of Langhoff-Roos21, focuses on potential avoidability.
Causal mechanisms are not mentioned.
The goal of a classification system
The goal of a classification system for registration of perinatal death should be to
give as much insight as possible in the underlying cause of death, in order to know if
and which preventive measures can be used for lowering perinatal mortality figures
in the future.
Using a uniform system, it will become possible to compare the incidences of causes
of death between countries or within countries between regions in order to
anticipate to it with the initiation of further studies.
This goal can be reached by a method that meets the following criteria:
- Easy to use by clinicians (gynaecologists, paediatricians) as well as (fetal)
pathologists by using uniform definitions which are not multi-interpretable.
- Easy to expand in terms of subclassification.
- Good level of agreement (low inter-observer variability).
- Based on clinical factors and necropsy findings including histology of the
placenta.
- Explaining the underlying cause of death (the factor that initiated the train of
events leading to death).
- Suitable in stillbirth and neonatal death.
- Resulting in high percentage classifiable cases and low percentage of
unexplained cases despite a thorough investigation.
We studied all the classification systems described above, regarding these criteria 
(table I).The Hovatta classification meets most of our criteria but is only suited for
stillbirth.Based on this classification we developed a  classification system using
simple principles of obstetrical and neonatal pathology based on the factor that
initiated the train of events leading to death.Therefore we called it a fundamental
classification system.We defined a priori that causes of pregnancy loss and perinatal
death are limited to a small number of classic categories of underlying pathological
conditions:birth trauma, infection,placenta or cord pathology,pathology of immune
tolerance between mother and fetus, congenital malformation of the fetus and
complications of a premature/immature delivery (table 2).
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Table 2
Classification of underlying cause of perinatal death
EXAMPLE OF CLINICAL
CLASSIFICATION SUBCLASSIFICATION MANIFESTATIONS
1. Trauma 1: Antenatal 1. Uterus rupture
2: At Birth 1. Cerebral Haemorrhage
2. Iatrogenous
3: Postnatal 1. Pneumothorax
2. Infection 1: Antenatal 1. Vaso-circulatory collaps
*  Haematogenous 2. Virus-mediated/death in hydrops
*   Transamniotic 1. Aspiration pneumonia
2: Postnatal 1. Sepsis neonatorum
3. Placenta/Cord 1: Acute/subacute 1. (Partial) abruption
Pathology 2. Cord prolapse/compromise
3. Marginal haemorrhage
4. Velamentous
insertion/vasolaceration
5. Infarction (> 10 %)
6. Fetal asphyxia eci
2: Chronic progressive 1. Abnormal development or
localisation (TTS in multiple
pregnancy,placenta praevia)
2. Intervillous thrombosis
3. PIH (terminal villus deficiency)
4. Diabetes mellitus 
5. Maternal thrombophilia
6. Feto-maternal haemorrhage
7. Villitis of unknown origin
4. Maternal Immunesystem 1: Bloodtype incompatibility 1. Rhesus antagonism
Pathology 2. AO-antagonism
3. Irregular antibodies
2: Bloodplatelet antibody 1. Auto-immune related
2. Allo-immune  HPA
5. Congenital Malformations 1: Hereditary 1. Autosomal dominant
Incompatible with life 2. Autosomal recessive
3. Sex chromosomal
2: Non-Hereditary 1. Syndrome
2. Association
3. Sequence
4. Disruption
5. Deformation
6. Prematurity/Immaturity 1: Cervixincompetence 1. RDS
Complications 2. Sepsis
2: Preterm labour iatrogenous 3. Coagulopathy/cerebral
haemorrhage
3: Preterm labour eci 4. Enterocolitis necroticans
7. Unclassificable 1: Despite thorough
investigation
2: Important information
missing
Material and Methods
From 1983 to 1992 a prospective registry of perinatal mortality was performed in
the Dutch healthcare region Delft-Westland-Oostland (DWO).This region has a
mixed urban and agricultural population of just over 215,000 inhabitants and a
stable birth-rate resulting in 28,983 still- and live- born infants during the study
period.The perinatal mortality rate of the region was 8.25 promille (n=239). All
pathological pregnancies were recorded prospectively according to home residence
(postal code) of the mother using hospital registration, a comprehensive Dutch
Perinatal Database (LVR), local Neonatal Database and Pathological Database of the
region.These data were cross-checked with the registration of perinatal mortality
concerning the region DWO by the Central Statistics Office of the Netherlands
(CBS).7 All  cases of perinatal  death, with a birth weight of 500 grams or more
according to WHO-definition for standard national perinatal death figures1 (n=239),
were included into the study. An autopsy was performed in 78% of the cases. All
postmortem examinations (fetal and neonatal) were carried out according to the
same protocol. (table 3).22,23 In 12% (29 cases) information about the cause of death
was only exactly known by the doctors who signed the death certificates for the
CBS and in 6% (15 cases) important information was missing to estimate a reliable
cause of death. So 195 cases were included in  this validation study. Four
gynaecologists and 2 paediatricians were asked to classify independently of each
other these 195 cases of perinatal mortality. They used the classification of
underlying causes of death (table 2) proposed by us,with the definitions mentioned
in table 4. They were not involved in the original development of the classification
system by the authors and were unfamiliar with the system.They worked
independently of each other in classifying all cases of perinatal death and were
unaware of the results of the classification of their colleagues.
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Table 3
Protocol analysis perinatal death
•  Full X-ray analysis
•  Physical dimensions against tables for standards gestational age
•  Macroscopic and microscopic examination of all organ systems (incl. neuropathological examination)
•  Registration of all congenital malformations (major and  minor)
•  Microbiological cultures (orifices, blood and urine)
•  Maternal TORCH-serology,Kleihauer test
•  Placental examination22,23
•  Genetic studies: Lymfocyte or skin fibroblast culture by a  registrated clinical genetic center
Fundamental classification of perinatal death
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Table 4
Definitions fundamental classification of perinatal death
1. Trauma:
Birth injuries caused by obstetrical complications and/or mode of delivery, caused antenatal, intra-
or postpartum.
Clinical manifestations: e.g. cerebral haemorrhage, asphyxia in difficult labour,uterus rupture
antenatal or intrapartum,cervical plexus laesions, iatrogenic caused pneumothorax.
2. Infection
-  Antenatal:
Haematogenous:A microbiological agens causes a haematogenous infection through the spiral
arteries, placenta,umbilical cord to the fetus.Clinical manifestations are circulatory collapse,
hydrops foetalis, growth retardation, fetal-maternal haemorrhage.
Transamniotic:Ascending infection from colonization of the birth canal causes infection of the
amniotic fluid with aspiration pneumonia of the fetus.
-  Neonatal:
Sepsis neonatorum due to infections acquired after birth.
3. Placenta/cord pathology:
- Acute/subacute placental pathology:Total or partial abruption of the placenta,placental
haematomata with intervillous thrombosis,marginal haemorrhage, subchorial haematoma,
placental infarction > 10%,velamentous  insertion with vasolaceration or compression of the cord,
cordprolapse/compromise. Sometimes no placental pathology can be found.Clinical manifestations
in the fetus are signs of asphyxia with (in the subacute fase) time to aspirate meconiumstained
amniotic fluid.
-Chronic/progressive placental pathology:
Placental maldevelopment like in multiple pregnancy (Twin-Twin transfusion Syndrome;TTS)
placenta praevia, uterine malformation or –septum.
Maternal circulation disorders and terminal villus deficiency like in pregnancy- induced-
hypertension (PIH),preeclampsia, thrombophilia. Also when coagulation disorders are found in
bloodsamples of the mother like in systemic lupus erythematosus (SLE).
Massive perivillous fibrin depositions.
Villitis of unknown origin.
Diabetic changes in the placenta: pale , large and immature villi with oedema.
Clinical manifestations of chronic placenta pathology in the fetus can be signs of small for
gestational age.
4. Maternal immune system pathology:
-Bloodtype antagonismn, incl.Rhesus.Death ascribable to bloodtype incompatibility.
-Bloodplatelet antibodies.
5. Congenital malformations:
- Hereditary: Autosomal dominant or recessive, sex chromosomal, hereditary coagulopathies.
All have interest in perinatal medicine and work in 3 different hospitals in the
Netherlands.
Statistical methods: Inter-rater agreement beyond chance between the classifiers
was calculated using Cohen’s Kappa, a statistic applicable to multiple observers and
multiple testresults. (SAS statistical software). An approximate qualitative
interpretation of the kappa statistic for inter-rater agreement beyond chance is
suggested: 0.4 Poor,0.40-<0.55 Fair, 0.55-<0.70 Good,0.70-<0.85 Very Good,≥ 0.85
Excellent. 24 Kappa-values and 95% confidence intervals (C I) for inter-observer
reproducibility were calculated with 6 raters, respectively.25
Results
Tabel 5 shows the distribution over the 7 categories of causes of perinatal death by
the 6 assessors. In the validation study 195 cases were included.Over each category
a kappa correlation-coefficient  with lower-upper confidence interval was
calculated.The correlation coefficients varied from 0.26 to 1.0.Reproducibility of
the categories trauma  and unclassifiable was poor with kappa coefficients of 0.26
(95% C.I. 0.22-0.30) and 0.36 (95% C.I. 0.32-0.40) respectively.The categories
infections and placental/cord pathology showed fair reproducibility with kappa’s of
0.50 and 0.62.The reproducibility of the judgment in the categories maternal
immune system pathology, congenital malformations and complications of
Chapter 5
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Continuation table 4
Definitions fundamental classification of perinatal death
- Non-hereditary: Syndrome, association, sequence,disruption,deformation.
Any genetic or structural defect arising at conception or during embryogenesis incompatible with
life or potentially treatable but causing death.
6. Immaturity/pre-viable delivery: complications of a very premature delivery (e.g. caused by
cervixincompetence,premature preterm rupture of membranes (PPROM), iatrogenous and eci)
with cerebral haemorrhage, idiopathic respiratory distress syndrome (IRDS), enterocolitis
necroticans and/or coagulopathy.When the premature delivery is an iatrogenic result of  an
underlying problem like an abruptio placentae, this cause should have priority. In cases of an intra-
uterine infection this should have priority as underlying cause.
7. Unclassifiable: Even with thorough investigation  the most probable cause could not  be
determined.
Lost for follow-up: Important information to classify the cause of death is missing.
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prematurity/immaturity was very good to excellent,with kappa-values of 1.0, 0.87
and 0.72  respectively.
An overall kappa-coefficient for multiple observers and multiple testresults was
calculated as 0.70 (95% C.I. 0.68-0.72). We found no differences taking the
professions  in consideration as the 2 paediatricians did not  classify significantly
different from the gynaecologists.
Discussion
Not only obstetricians but epidemiologists and sociologist as well are involved in
the study of perinatal mortality. Perinatal mortality continues to be an important
standard for the quality of perinatal care.Comparison of perinatal mortality figures
requires uniform definition,uniform classification and reliable registration. All these
requirements have not met till so far.
- Perinatal mortality is not uniformly defined.There are significant differences
Fundamental classification of perinatal death
Table 5
Correlation coefficients over 7 categories by 6 assessors
Diagnose Kappa’s * Lower/upper
correlation- coefficients confidence Interval
1.Trauma 0.26 0.22-0.30
2. Infection 0.50 0.46-0.54
3.Placenta/cord 0.62 0.58-0.65
pathology
4.Maternal 1.00 0.96-1.00
immunesystem
pathology
5.Congenital 0.87 0.84-0.91
malformations
(lethal)
6.Prematurity/ 0.72 0.68-0.76
immaturity
complications
7.Unclassifiable 0.36 0.32-0.40
Overall Kappa 0.70 0.68-0.72
* Interpretation of the Kappa statistic for interrater agreement according to Fleiss24
< 0.4 is poor
0.40-< 0.55 is fair
0.55-< 0.70 is good
0.70-< 0.85 is very good
≥ 0.85 is excellent
between countries of the world. As the neonatal survival figures improved very
much in the last decade, a definition using 24 weeks or 500 gram is more
realistic.2 Furthermore a 7-day limit in neonatal death registration is not a
natural cut-off point as the moment of death can be dependent of the
management by the paediatrician.To use 28 days as a comparison of departments
can be expected to give more comparable information.
- The registration of the first week mortality in several countries is far from
complete as long as the databases of obstetricians and paediatricians are not
linked.
- Perinatal mortality, in particular in the western countries is so low that the
mortality rate per obstetric department does not allow to draw reliable
conclusions on the quality of perinatal care. Furthermore, it is difficult to
compare perinatal mortality rates of departments if no correction for population
differences is made.26 Registration of perinatal mortality makes more sense if it
can lead to prevention and to a well-established pre-conceptional advice in
women with an history of perinatal mortality.This is not possible if mortality is
only registered as such and the underlying cause is not registered.The nowadays
used classification systems are not used frequently as they have the drawbacks
mentioned above.Likewise perinatal audit committees that use qualifications as
not-avoidable, probably (not) avoidable, avoidable or suboptimal care factors
should have the opportunity to see in which class and therefore in which
direction one should look for preventive measures in  avoidable cases.
In our opinion, an easy to use classification system with a good inter-observer
reproducibility, based on the underlying cause of death,makes registration of
perinatal mortality figures more significant.Knowledge of the underlying causes of
perinatal death will be helpful in the discussion about suboptimal care and
preventability.Our classification system appears to be suitable for the study of the
backgrounds of perinatal mortality.The factor that initiated the train of events
leading to death: e.g. in a case of a normally grown  preterm baby that was delivered
by caesarean section due to a partial abruption of the placenta and that died of
respiratory problems or cerebral bleeding, the underlying cause of death using our
model is the placental abruption.That does not exclude that the direct cause of the
death can be respiratory insufficiency.Classification of perinatal mortality should be
used in every perinatal practice and be incorporated into a Perinatal Database.
A good level of inter-rater agreement by individuals as shown in our system (overall
kappa-statistic of 0.70) may suggest an even greater agreement when judgments are
made by  a panel consisting of an obstetrician,paediatrician and (fetal) pathologist.
As Settatree stated “identical assignments by assessors reported as a ‘panel
agreement’ will thus be better than individual pairings.”14Therefore we advise to use
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regional clinicopathological conferences to achieve an even higher level of
agreement.
The wide range in some of the categories as shown in table 5, (i.e. placental
pathology and pre-viable delivery) implies that clear definitions and uniform
instructions how to use them are necessary.The poor agreement in the category
trauma can be explained by the fact that the numbers in this category were small
(n=2 in our evaluation study).27 Poor agreement in the category unclassifiable can be
explained by the fact that some classifiers only used one of the six categories if
there was no doubt at all about the underlying cause,while others used ‘the most
probable cause of death’. Exchanging experiences with this model on a web-site
should lead to a fast spreading and a further improvement in the application of the
model. Proposals for further subclassification can easily be introduced.
Determination of  the ‘most probable’ cause of death in cases of less than 100%
certainty about the diagnose, can further reduce the percentage of unclassifiable
cases.
Our system is brief, gives a good agreement and appears to be simply applicable. It
gives possibilities for recognising preventive factors in future pregnancies and will
make (inter)national trends and comparisons in perinatal death causes possible. A
classification based on the underlying cause should contribute to improvement of
the quality of perinatal care.
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Chapter 6
Evaluation of 239 cases of perinatal death
Using a fundamental classification system
A.E.M.de Galan-Roosen, J.C.Kuijpers, P.J.C. van der Straaten, J.M.W.M.Merkus 
Eur J Obstet Gynecol Reprod Biol 2002, vol.103/1
Abstract
Objective:To classify 239 cases of perinatal death in a newly introduced classification
system for underlying causes of perinatal death.
Design:Prospective,descriptive.
Setting:Dutch healthcare region Delft-Westland-Oostland (DWO).
Material and Methods: In 10 years (1983-1992) all cases of perinatal death with a
birthweight of 500 grams or more (n=239) were included into the study.We used a
classification model based upon the underlying cause of death using simple
principles of obstetrical and neonatal pathology. A team consisting of a
gynaecologist, neonatologist and pathologist classified all cases of perinatal death
into 7 groups to determine the ‘most-probable’ cause of death.
Results:Birth trauma was seen in 2 cases (0.8%). Infections were seen in 16 cases
(6.8 %). Acute/subacute placental pathology in 77 cases (32.2%) and chronic
placental pathology in 50 cases (21%). Bloodtype antagonism was seen in 2 cases
(0.8%).Lethal congenital malformations in 55 cases (23%).Complications of pre-
viable delivery in 20 cases (8.4%).Unclassifiable were 17 cases (7%):2 cases could
not be classified despite thorough investigation (1%) and 15 cases were lost for
follow-up (6%).
Conclusions: Classification of perinatal causes of death by using our fundamental
classification system gives insight in the possible underlying causes of death.The
results of such a classification can be used as guidelines for preventive measures in
the future.
Key words: Perinatal mortality, epidemiology, registration, classification,underlying
cause of death.
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Introduction
Perinatal mortality rates are used as quality standards for obstetric and neonatal
healthcare.Nevertheless, publications providing detailed information on the
pathogenesis and underlying causes of perinatal mortality, especially those based on
population information are rare.1,2
Information on the underlying cause of perinatal mortality however is needed in
order to know which measures can lead to improvement of the perinatal care.
We classified the underlying cause of the perinatal mortality cases during a 10 year
period in a region representative of the Dutch population using a model described
elsewhere.3
Materials and methods
During the decade of 1983 to 1992 a prospective analysis of perinatal mortality was
performed in the Dutch healthcare region Delft-Westland-Oostland (DWO).This
region has a mixed urban and agricultural population of just over 215,000
inhabitants with an ethnic background  representative for the Dutch population4 and
a stable birth rate resulting in 28,983 still- and liveborn infants during the study
period. All pathological pregnancies were recorded prospectively according to
home residence (postal code) of the mother using hospital registration, a
comprehensive Dutch Perinatal Database (LVR), local Neonatal Database and
Pathological Database of the region.These data were crosschecked with the
registration of perinatal mortality concerning the region DWO by the Central
Statistics Office of the Netherlands (CBS).5The perinatal mortality rate of the
region during the study period was 8.25 promille (239/28.983).Based on the specific
characteristics of obstetrical care in the Netherlands, approximately 55% of all
deliveries either took place at home or in an outpatient setting. All pathology
however is managed at clinical level resulting in a complete registration of perinatal
death. All 239 cases of perinatal death were included into the study concerning 151
cases of stillbirth (a weight criterium of ≥ 500 grams is used for the standard
national perinatal death figures according to the WHO-definition6) and 88 cases of
neonatal death (liveborn children ≥ 500 grams who died within 7 x 24 hours
postnatally).The autopsy rate was 78%. All postmortem examinations (fetal and
neonatal) were carried out according to the same protocol.3 Based on both clinical
and pathological findings and the results of clinicopathological conferences by a
team (consisting of a gynaecologist, a paediatrician and a paediatric pathologist),one
‘most probable’ cause of death was defined using a fundamental classification model
based on simple principles of obstetrical pathology  into 7 groups of diagnoses
(table I). For definitions see table 2.
Evaluation of 239 cases of perinatal death
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Table 1
Classification of underlying cause of perinatal death
EXAMPLE OF CLINICAL
CLASSIFICATION SUBCLASSIFICATION MANIFESTATIONS
1. Trauma 1: Antenatal 1. Uterus rupture
2: At Birth 1. Cerebral Haemorrhage
2. Iatrogenous
3: Postnatal 1. Pneumothorax
2. Infection 1: Antenatal 1. Vaso-circulatory collaps
*  Haematogenous 2. Virus-mediated/death in hydrops
*   Transamniotic 1. Aspiration pneumonia
2: Postnatal 1. Sepsis neonatorum
3. Placenta/Cord 1: Acute/subacute 1. (Partial) abruption
Pathology 2. Cord prolapse/compromise
3. Marginal haemorrhage
4. Velamentous
insertion/vasolaceration
5. Infarction (> 10 %)
6. Fetal asphyxia eci
2: Chronic progressive 1. Abnormal development or
localisation (TTS in multiple
pregnancy,placenta praevia)
2. Intervillous thrombosis
3. PIH (terminal villus deficiency)
4. Diabetes mellitus 
5. Maternal thrombophilia
6. Feto-maternal haemorrhage
7. Villitis of unknown origin
4. Maternal Immunesystem 1: Bloodtype incompatibility 1. Rhesus antagonism
Pathology 2. AO-antagonism
3. Irregular antibodies
2: Bloodplatelet antibody 1. Auto-immune related
2. Allo-immune  HPA
5. Congenital Malformations 1: Hereditary 1. Autosomal dominant
Incompatible with life 2. Autosomal recessive
3. Sex chromosomal
2: Non-Hereditary 1. Syndrome
2. Association
3. Sequence
4. Disruption
5. Deformation
6. Prematurity/Immaturity 1: Cervixincompetence 1. RDS
Complications 2. Sepsis
2: Preterm labour iatrogenous 3. Coagulopathy/cerebral
haemorrhage
3: Preterm labour eci 4. Enterocolitis necroticans
7. Unclassificable 1: Despite thorough
investigation
2: Important information
missing
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Table 2
Definitions fundamental classification of perinatal death
1. Trauma:
Birth injuries caused by obstetrical complications and/or mode of delivery, caused antenatal, intra-
or postpartum.
Clinical manifestations: e.g. cerebral haemorrhage, asphyxia in difficult labour,uterus rupture
antenatal or intrapartum,cervical plexus laesions, iatrogenic caused pneumothorax.
2. Infection
-  Antenatal:
Haematogenous:A microbiological agens causes a haematogenous infection through the spiral
arteries, placenta,umbilical cord to the fetus.Clinical manifestations are circulatory collapse,
hydrops foetalis, growth retardation, fetal-maternal haemorrhage.
Transamniotic:Ascending infection from colonization of the birth canal causes infection of the
amniotic fluid with aspiration pneumonia of the fetus.
-  Neonatal:
Sepsis neonatorum due to infections acquired after birth.
3. Placenta/cord pathology:
- Acute/subacute placental pathology:Total or partial abruption of the placenta,placental
haematomata with intervillous thrombosis,marginal haemorrhage, subchorial haematoma,
placental infarction > 10%,velamentous  insertion with vasolaceration or compression of the cord,
cordprolapse/compromise. Sometimes no placental pathology can be found.Clinical manifestations
in the fetus are signs of asphyxia with (in the subacute fase) time to aspirate meconiumstained
amniotic fluid.
-Chronic/progressive placental pathology:
Placental maldevelopment like in multiple pregnancy (Twin-Twin transfusion Syndrome; TTS)
placenta praevia, uterine malformation or –septum.
Maternal circulation disorders and terminal villus deficiency like in pregnancy- induced-
hypertension (PIH),preeclampsia, thrombophilia. Also when coagulation disorders are found in
bloodsamples of the mother like in systemic lupus erythematosus (SLE).
Massive perivillous fibrin depositions.
Villitis of unknown origin.
Diabetic changes in the placenta: pale , large and immature villi with oedema.
Clinical manifestations of chronic placenta pathology in the fetus can be signs of small for
gestational age.
4. Maternal immune system pathology:
-Bloodtype antagonismn, incl.Rhesus.Death ascribable to bloodtype incompatibility.
-Bloodplatelet antibodies.
5. Congenital malformations:
Hereditary: Autosomal dominant or recessive, sex chromosomal, hereditary coagulopathies.
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Table 3
Causes of perinatal death region DWO 1983-1992
Classification Stillbirth neonatal death Total %
< 7 days
1.Birth trauma 1 1 2 0.8
2. Infection
a. transamniotic 1 5 6 2.5
b.haematogenous 9 1 10 4.3
3.Placental pathology
a. acute/subacute 62 15 77 32.2
b. chronic/progressive 39 11 50 21.0
4.Maternal immunesystem
pathology
a.bloodgroup antagonism 1 1 2 0.8
b.bloodplatelet antibody - -
5.Congenital malformations
a.hereditary 1 1 2 0.8
b.non-hereditary 22 31 53 22.2
6.Prematurity/immaturity - 20 20 8.4
7.Unclassifiable 15 2 17 7.0
Total 151 88 239 100
Continuation table 2
Definitions fundamental classification of perinatal death
- Non-hereditary: Syndrome, association, sequence,disruption,deformation.
Any genetic or structural defect arising at conception or during embryogenesis incompatible with
life or potentially treatable but causing death.
6. Immaturity/pre-viable delivery: complications of a very premature delivery (e.g. caused by
cervixincompetence,premature preterm rupture of membranes (PPROM), iatrogenous and eci)
with cerebral haemorrhage, idiopathic respiratory distress syndrome (IRDS), enterocolitis
necroticans and/or coagulopathy.When the premature delivery is an iatrogenic result of  an
underlying problem like an abruptio placentae, this cause should have priority. In cases of an intra-
uterine infection this should have priority as underlying cause.
7. Unclassifiable: Even with thorough investigation the most probable cause could not be
determined.
Lost for follow-up: Important information to classify the cause of death is missing.
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Results
Table 3 shows the distribution of  causes of death in stillbirth and first-week
neonatal death.
Trauma: In one case of stillbirth there was a severe shoulder-dystocia (trauma at
birth) in a diabetic mother, the baby had a birthweight of over 4600 grams, and in
one case of neonatal death there was a Turner’s syndrome with hygroma cysticum
which caused a dystocia at birth and difficulties with mechanical ventilation
afterwards (neonatal trauma).
Infection:
1)A transamniotic infection causing a sepsis was found in 6 cases of perinatal death.
In 3 cases a positive culture of the fetus and/or placenta could be demonstrated:
One case of  Haemolytic Streptococcus Group B, 1 case of Neisseria Meningitidis and
1 case of Bacteroides Fragilis.Cultures remained sterile despite a clinical sepsis and
aspiration pneumoniae in 3 other cases.
2)Villitis in the placenta, indicating a haematogenous perinatal infection,was found in
10 cases of perinatal death. In 5 cases it was possible to detect an elevation of the
Table 4
127 cases of placental pathology in a total group of 239 cases of perinatal death
Diagnoses Stillbirth Neonatal death < 7 days
N % N %
I  acute/subacute placental pathology 62 26.0 15 6.2
1. (partial) abruptio 39 2
2. cord prolapse 2 1
3.marginal haemorrhage 1
4. infarction (> 10 %) 3
5. velamentous insertion/vaso-laceration 7
6.others 10 12
II Chronic progressive placental pathology 39 16.0 11 5.0
1.placental maldevelopment 17 4
(multiple pregnancy,uterine septum,placenta
praevia, chorangioma.)
2.PIH, terminal villus insufficiency 7 3
3.Diabetes mellitus 3 1
4.maternal coagulopathy /thrombophilia 6 3
5.others (like villitis of unknown origin) 6
Total 101 42.0 26 11.2
IgM–titer (3 CMV and 2 Rubella  infections.)  Signs of focal infiltration of the villi
with lymphocytes and histiocytes causing necrosis of the villi were pathognomic for
a perinatal infection in 5 other cases.
Placental pathology: (table 4) A (sub)acute placental problem ((partial) abruptio
or cordprolapse) was seen in 41 cases of stillbirth and 3 cases of neonatal death
(44/77 is 57%). In the infant only signs of acute asphyxia could be found. A
velamentous insertion with cord compromise or vasolaceration was seen in 9%
(7/77 ). Placental infarction (> 10%) was recorded in 3 cases (3.9%).
Chronic progressive placental pathology, caused by maldevelopment,was seen in
42% (21/50). In 16 of the cases there was a twin/triplet pregnancy.During the study
period 324 multiple pregnancies were seen:317 twins and 7 triplets.The perinatal
mortality rate of the total amount of multiple pregnancies was 2.9% (19/655).
Maternal immune system pathology: Bloodtype antagonism (AO) and rhesus- 
antagonism were a cause of death in 1 case of stillbirth and 1 case of neonatal death.
Congenital malformations: 23% (55/239) of the total perinatal mortality and 36%
(32/88) of the neonatal deaths was caused by a lethal congenital malformation. In the
stillbirth group the most common lethal congenital malformations are the central
nervous system anomalies. In neonatal death cardiovascular anomalies and
pulmonary hypoplasia are the most important contributors to lethal congenital
malformations.
Prematurity/immaturity complications: In 8.4% (20/239) an extremely preterm
delivery (before 28 weeks of gestation) with severe complications as idiopatic
respiratory distress syndrome, sepsis and/or a cerebral haemorrhage was a cause of
death.Causes of the extremely preterm delivery were classified as
cervixincompetence,Preterm Prelabour Rupture of Membranes (PPROM) without
signs of infection, iatrogenous induced labour and unknown.
Unclassifiable : In 2 cases (1%) the cause of death remained unknown,despite a
thorough investigation. In another 15 cases most information was lost for follow-up
so it appeared to be impossible to estimate a reliable cause of death (6%).
Discussion
Large international differences in the definition of perinatal mortality still exist. Also
within Europe different definitions are used which do not lead to a reliable
comparison of perinatal mortality figures. In our study in the Delft-Westland-
Oostland (DWO) healthcare region which can be considered representative of the
Netherlands,4 we used a birthweight criterium of 500 grams or more,which was
advocated by the WHO for national comparison.For international comparison of
perinatal death figures the WHO recomments a weightcriterium ≥ 1000 grams.6 In
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the 10th  revision of the International Classification of Diseases (WHO) in 1992 it is
advised to define  perinatal mortality as perinatal death after 22 weeks of gestation
i.e. the time when birth weight is normally 500 grams and ending within 7 days
postnatally.7 We made the inclusion for a weight criterium ≥ 500 grams as many
children (> 60% in 1993)  survive at present above a birth weight of 500 grams.8
If international agreement about the definition of perinatal mortality is achieved and
a reliable registration of all cases of perinatal mortality is made possible, there will
be the need  to get insight in the differences of the perinatal causes of death
between countries or within countries between regions.Using our fundamental
classification system 3 main causes of perinatal mortality could be registered:
placental pathology, lethal congenital malformations and infections.
In the literature, an ascending infection which causes an aspiration pneumonia
and/or neonatal sepsis, causes perinatal death in 8.3% of the newborn.9 In our study
2.5% of the perinatal death cases were classified as an ascending infection, although a
chorioamnionitis was seen far more often (6 out of 27 cases of chorioamnionitis
had a positive culture of the placenta or the fetus).Haematogenous caused
infections like viral and protozoal infections (Cytomegalovirus,Rubella,Mycoplasma
and Toxoplasmosis) can be the cause of villitis in the placenta.CMV infections are
important contributors to brain damage and senso-neuronal hearing loss in children
but can also cause perinatal deaths.10 More effort should be focused on primary
prevention of congenital infections as was reached by the Rubella vaccination in the
past.
In the case of placental pathology two subcategories are made:
At first acute/subacute placental pathology (the acute form inclusive of massive
abruption, cord abruption or other forms of fatal cord compromise),with acute
asphyxia of the child as outcome. In cases of sub-acute placental pathology like
partial abruption,marginal haemorrhage, intervillous thrombosis and velamentous
insertion with vasolaceration, the child has time to respond with: fetal bloodhypoxia,
cessation of pulmonary fluid secretion,meconiumpassage and aspiration as well as
hypoxic damage to the endothelium.
The (partial) placental abruption 41/77 (53%) plays an important role in the
acute/subacute placenta pathology category. An abruptio is often considered to be
unpredictable and unavoidable.However in several case-control studies increased
thrombophilic defects and hyperhomocysteinaemia are demonstrated. In cases of
placental abruptio the prevalence of thrombophilic defects was about 60%.11,12
Secondly chronic/progressive placental pathology such as may be found in placental
maldevelopment,multiple pregnancy,Pregnancy-Induced-Hypertension and
maternal coagulopathy. A chronic infection with an unknown agens (villitis of
unknown etiology)13 or an abnormal immune reaction to maternal cells causes an
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inflammation with necrosis and destruction of placental villi with negative effects on
the pregnancy outcome.14This may result in intra-uterine growth retardation as
these situations have a longer space of time.With several other authors11,12,15-17 we
think that an underlying thrombophilic status of the mother/fetus may influence the
placental flow in an adverse direction, causing complications in pregnancy like pre-
eclampsia, intra-uterine growth retardation, (recurrent) miscarriage and stillbirth.18
The paternal role in this mechanism remains often unclear and should be clarified.
Several studies have shown the influence of a thrombophilic defect in the fetus. It
may lead to thrombosis in the fetal placental circulation with negative effects on the
feto-maternal circulation.15,16,18,19 It is our opinion that more studies to the impact of
thrombophilia and perinatal mortality are needed especially as far as combinations
of thrombophilic defects are concerned.
Lethal congenital malformations are found in our study in 23% of the cases,
including neonatal deaths.Most studies found a stable percentage between 8 and
36% of congenital malformations in stillborn fetuses.20,21 In an earlier publication we
described all congenital malformations (minor and major). In 5 cases details were
missing, they were not included in the study in 1998.22 Since the screening for
congenital malformations by ultrasound only can reduce the incidence of perinatal
mortality due to congenital malformations by secondary prevention23 more effort
should be made in primary prevention of congenital malformations. A recent
example is the prevention of neural tube defects by peri-conceptional folic acid
suppletion.
Classification of perinatal death causes gives possibilities for recognising preventive
factors in future pregnancies and uniform classification will make (inter)national
comparisons in perinatal causes of death possible.Knowing the underlying causes of
perinatal death it becomes more relevant to study avoidability and substandard care
factors.
In the Netherlands our classification model can be incorporated in a new national
Perinatal Database such as the LPR,which has been developed recently in order to
connect both the national perinatal database (LVR ) and the national neonatal
database (LNR).By doing so it will become possible to make  hospital-based,
regional and national comparisons in perinatal causes of death.This will attribute to
a higher level of pre-conceptional, prenatal and perinatal care.
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Part 1II
R I S K  FAC TO R S  F O R  P E R I N ATA L
M O RTA L I T Y
Introductory remarks
Laboratory data and history data are presented  in relation with thrombophilia.
Between 1999 and 2000 the prevalence of thrombophilia and thromboembolic
events was studied in 74 women and their partners with a history of perinatal death.
These women and men were a subdivision from the total cohort of 239 women
with a history of perinatal death during the period 1983-1992 and described in parts
I and II. As a control group 71 healthy,unrelated women and their partners,with
uneventful preceding pregnancies,were recruited by advertisement. For the
classification of causes of death our system,as presented in part II,was used.
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Maternal and paternal thrombophilia:
risk factors for perinatal mortality
A.E.M.de Galan-Roosen, J.C.Kuijpers, F.R.Rosendaal, E.A.P. Steegers,
W.A.M.van Beers,G.A.E.Ponjee,H.A.Bremer, J.M.W.M.Merkus
Abstract
Background:Although some paternal components to the predisposition to
preeclampsia have been demonstrated recently, it is not known whether such
paternal role contributes to thrombophilia-related perinatal mortality.
Methods:Data from a prospective registry of perinatal mortality in a Dutch
healthcare region were used.Between December 1999 and May 2000 the
prevalence of thrombophilia was studied in 74 women with a history of perinatal
mortality (female cases) and 54 of their male partners (male cases). Seventy-one
healthy unrelated women after uneventful pregnancies only and 66 of their male
partners were used as controls.
Results:The frequency of antithrombin deficiency (12% vs 0%), increased APC
resistance (32 vs 6%), total protein S deficiency (11% vs 1%) and elevated factor
VIII:C activity (43% vs 17%) was significantly higher in female cases as compared to
controls. In male cases the frequency of increased APC resistance was significantly
higher as compared to controls (22% vs 0%). In 30 of the 54 couples with a history
of perinatal mortality more than one thrombophilic abnormality was found (55%) as
compared to 10 of the 62 control couples (17%).
Conclusion:The risk of having thrombophilia is doubled in women as well as in men
with a history of perinatal mortality.
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Introduction
In the western world between 0.5 to 1% of all children,born with a birth weight
> 500 grams,end in perinatal death.1
Perinatal mortality may be lowered if risk factors for perinatal mortality can be
detected and adequate preventive measures are available.Maternal thrombophilia is
considered to be such a risk factor.Thrombophilia has been related to pregnancy
associated thrombosis and vascular related complications of pregnancy including
preeclampsia intrauterine growth retardation, abruptio placentae, recurrent
miscarriage and late fetal loss.2-10 As much as  65 percent of those vascular
complications  may be accounted for by some form of inherited or acquired
thrombophilia.11
Several studies have supported the hypothesis that  fetal loss is greater in women
with thrombophilic defects.12,13 In previous studies, 80 percent of the carriers of a
thrombophilic genetic defect who experienced ‘unexplained’ fetal death,
demonstrated placental thrombosis, infarctions and extensive perivillous fibrin
deposition.10 In preeclampsia ,maternal as well as paternal genes, expressed in the
fetus and the trophoblast,may play a part.14The aim of our study was to investigate
the prevalence of both maternal and paternal thrombophilia in parents who
experienced at least one episode of perinatal mortality and compare it to a control
group of parents with uncomplicated preceeding  pregnancies.
Methods
Patients and controls:
During the decade of 1983 to 1992 a prospective registry of perinatal mortality was
performed in the Dutch healthcare region Delft-Westland-Oostland (DWO).15
All cases of perinatal death with a birth weight of 500 grams or more - according to
the definition of the World Health Organisation (WHO) for standard national
perinatal death figures16-  were included into the study (n=239).The perinatal
mortality rate of the region during that period was 8.25 per thousand.The reliability
of these perinatal death figures was studied earlier and proved to be adequate as
over 99% of all cases were registered.17
Between December 1999 and May 2000, these women and their male partners
were approached by mail to participate in a blood draw. For 59 of the 239 women
no recent address could be traced.No response was obtained of another 70
women and 36 women refused to participate. So 74 women (female cases)
remained for further study.Perinatal death involved was subsequently classified
according to the methods as described earlier and shown in table 1.15 Seven women
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experienced  more than one perinatal death.Concerning the male partners of these
74 women, two men recently died of sudden heart death,10 were divorced and 8
refused participation. So 54 male partners (male cases) remained for further study.
Seventy-one control women and 66 of their partners were recruited by
advertisement.Their year of birth had to be between 1950 and 1970 as women with
a history of perinatal mortality were born in this period as well.Control women had
no malformations.They had no history of perinatal mortality or recurrent
miscarriage,nor were they pregnant at the time of participation in the study.The
study was approved by the local medical-ethical committee and all women and their
partners gave informed consent.
Blood was collected by venapuncture between 8 and 10 a.m. in all women and
partners after fasting overnight.Citrated (0.105 M trisodiumcitrate) blood samples
were used for the analysis of protein C activity (PCAct), antithrombin activity (AT)
and factor VIII activity (F VIII:C), total protein S antigen (PSAg) and free protein S
antigen (free PSAg) concentration, activated protein C resistance (APC-R) as well as
DNA analysis for thrombophilia related mutations: Factor V G1691A (F V Leiden),
Protrombin G20210A and Methylenetetrahydrofolatereductase (MTHFR) C677T.
EDTA blood samples were taken to measure homocysteine concentrations and
plasma anticardiolipid IgG and IgM antibodies (ACA-IgG,ACA-IgM).Blood samples
were immediately centrifuged at 2000g for 20 min., snap frozen in small aliquots and
stored at –80˚C.
Laboratory tests
All functional clotting assays were performed on an Electra 1600C Automatic
Coagulation Analyzer (Instrumentation Laboratory,Milano, Italy) PCAct and AT
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Table 1
Classification of perinatal death
Classification of Present
perinatal death15 study (n=74)
Infection 6
Placental pathology 46
Maternal immunesystem pathology
-  bloodtype incompatibility 1
Congenital malformations 17
Complications of immaturity / prematurity 4
Total 74
were determined by chromogenic assays (Chromogenix,Milano, Italy). F VIII:C was
performed as a two-step clotting assay using factor deficient plasma of Dade
Behring AG (Marburg,Germany). Anticoagulant response to APC (APC-R) was
defined as the ratio of the clotting times obtained in the presence and absence of
APC (Coatest APC Resistance,Chromogenix). APC-R was defined to be increased
when the sensitivity ratio (SR) was <1.8.PSAg was quantitated with specific enzyme
linked immunosorbent assays (ELISA;Dakopatts Copenhagen,Denmark). Free PSAg
was separated from PS-C4BP complexes by precipitation with PEG 2000. ACA-IgG
and ACA-IgM plasma levels were established by ELISA (Quanta lite ACA IgG and
IgM, Inova diagnostics Inc,Netherlands). For the determination of fasting plasma
homocysteine levels, high-performance liquid chromatography (HPLC) technique
was used.
For the molecular diagnosis of factor V Leiden, the prothrombin G20210A mutant
and the C677T MTHFR mutation,DNA was isolated from blood by the QIAamp
DNA Blood Mini Kit (Qiagen,GmbH,Hilden,Germany).Multiplex PCR was
performed by amplifying specific sequences of Factor V (F V), prothrombin ( F II) and
MTHFR genes by multiple primer sets.The PCR products were simultaneously
analysed  by  reverse hybridisation with specific probes for FV Arg506Gln and FII
G20210A and C677T MTHFR on a Line Probe Assay (LiPA) in a semi-automated
assay.18
Statistical Analysis
Data analysis was performed with the Statistical Package for Social Sciences for
Windows, version 10.0 (SPSS,Chicago,USA).Numerical data were summarized with
means and standard deviations, categorical data with numbers and percentages.
Relative risks of perinatal death associated with laboratory abnormalities were
expressed as odds ratios,with 95% confidence intervals according to Woolf.19
Adjustment for putative confounders was performed with unconditional logistic
regression.The cut-off levels were the reference values of the laboratory.
Results
The characteristics of men and women in the study and control groups are
presented in table 2.Parity and age at the time of study were significantly higher in
female cases as compared to controls.The use of oral contraceptives was not
significantly different between the two groups.There was no difference in age
between the male cases (median 42, range 35-61 ) and the controls (median 41,
range 31-53).
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Table 2
Population characteristics 
Characteristic Female Cases * Female Controls P OR
(n=74) (n=71) value (95% c.i.)
no. % no. %
Age     median 41 39 0.02
range 32-56 27-50
Parity median 3 2
range 2-7 2-4 < 0.001
Contraceptive use 18             24 13             18 0.42 1.4 
(0.6-3.2)
* Female cases are women with perinatal death ≥ 500 grams
Table 3
Thrombophilic factors in women
Thrombophilic Cut-off Female cases Female P-
factors values (n=74) controls (n=71) value OR (95% c.i.)
no. % no. %
AT <80% 9 12 0 0 0.003 ∞
APC-R SR<1.8 24 32 4 6 <0.001 8.1 (2.6-24.6)
PCAct <70% 1 1 0 0 1.00 ∞
Total PSAg <70% 8 11 1 1 0.03 8.5 (1.0-69.4)
Free PSAg <20% 2 3 0 0 0.50 ∞
F VIII:C >150% 32 43 12 17 0.001 3.8 (1.8- 8.1)
Homocysteine >15µmol/l 0 0 3 4 0.11 ∞
ACA-IgM >20GPL 4 5 1 1 0.37 4.1 (0.4-37.2)
ACA-IgG >15MPL 5 7 8 11 0.56 1.6 (0.5- 5.2)
Prothrombin mutation 3 4 5 7 0.49 0.6 (0.1- 2.4)
Factor V Leiden 7 10 8 11 0.79 0.8 (0.3- 2.4)
MTHFR mutation 43 58 32 45 0.14 1.7 (0.9- 3.3)
Number of values outside the cut-off
value*) none 22 30 48 70
1 27 37 17 25
2 14 19 4 6 <0.001 ∞
3 9 12 0 0
4 1 1 0 0
MTHFR mutation in combination
with other thrombophilic factors 0.003
Wild type 31 42 39 56 1 (-)
MTHFR mutation without other factor 16 22 23 33 0.3 (0.1- 0.6)
MTHRF mutation with other factor(s) 26 36 8 11 0.2 (0.1- 0.6)
*)
In the cases there was 1 missing value, in the controls there were 2 missing values.
}
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Women
The distribution of causes of  perinatal death investigated in this study was in
accordance with the distribution in the total group of 239 cases.15
The frequencies of AT deficiency, total PSAg deficiency, elevated Factor VIII:C levels
and increased APC-R,were significantly higher in female cases as compared to
controls.Neither the prevalence of PCAct deficiency, free PSAg deficiency,
hyperhomocysteinaemia, elevated ACA antibodies, FV Leiden mutation,
prothrombin mutation nor the MTHFR mutation was significantly different between
the two groups.
The percentage of women with one or more thrombophilic factor was 70% (51/73)
compared with 30% (21/69) in control women.The MTHFR gene mutation was
more often seen in combination with other thrombophilic factors in cases
compared with controls (36 vs 11%; table 3).
Men
In  male cases significantly more frequently  increased APC-R was found as
compared to controls.The differences in the frequency of the other thrombophilia
factors were not significant.The percentage of the cases with a thrombophilic factor
was 60% (32/54) compared with 30% (19/64) in the controls.The MTHFR gene
mutation was more often seen in combination with other thrombophilic factors in
cases compared with controls (43 vs 13%; table 4).
Couples
If the results were analysed for couples (one anomaly in either parent) similar
results were found.The odds ratio’s of the couples were high for abnormally low AT
(odds ratio 15.3,95% c.i. 1.9-123), increased APC-R (OR 9.6,95% c.i. 3-30) and low
total PS Ag (OR 10.4,95% c.i. 1.3-86; table 5).
In 30 of the 54 couples with  a history of perinatal death more than one thrombotic
risk factor was found (55%) compared with 10 of the 62 control couples (17%).The
MTHFR gene mutation was more often seen in relation to other thrombophilic
factors in couples of cases compared to control couples ( 67 vs 38%; table 5).
Discussion
This study shows that the prevalence of thrombophilia is doubled in women (30 vs
70%) as well as in men (30 vs 59%) with a history of perinatal mortality (tables 3 and
4).Previous studies that investigated paternal contribution to perinatal death,
however, found no contribution of the father concerning thrombophilia 
Preston et al. found no significant difference in fetal mortality in women whose
partners had  thrombophilia (n=311) as compared to  that of women whose
partners had no known thrombophilia (n=84).12This can be explained by the low
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frequency of fetal loss.Gris et al. performed a case-control study similar to ours in
women and their partners with late fetal loss.They excluded,however,
thromboembolic events in the past for both men and women.9The absence of an
effect of the paternal genotype in that study may well have been the result of this
exclusion criterion since a relation between a history of thromboembolic events
and perinatal mortality is highly probable.
A paternal role in adverse pregnancy outcome was suggested  in a study showing an
association between preeclampsia and changing paternity.14 Esplin et al. found
evidence for paternal as well as maternal components of the predisposition to
preeclampsia.20 Zusterzeel found the Glutathione S-transferase Pi gene val105/ val105
genotype significantly more often in mothers and fathers in cases of preeclampsia.21
In perinatal death however, the contribution of this mutation is still unclear.
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Table 4
Thrombophilic factors in men
Thrombophilic Cut-off Male cases Male controls P-
factors values (n=54) (n=66) value OR (95% c.i.)
no. % no. %
AT <80% 5 9 1 2 0.09 6.5 (0.7-57.7)
APC-R SR <1.8 12 22 0 0 <0.001 ∞
PCAct <70% 0 0 1 2 1.00 ∞
total PSAg <70% 1 2 0 0 0.45 ∞
free PSAg <20% 0 0 0 0 1.00 ∞
F VIII:C >150% 12 22 13 20 0.82 1.1 (0.5-2.8)
Homocysteine >15µmol/l 4 7 7 11 0.75 0.7 (0.2-2.4)
ACA-IgM >20GPL 3 6 1 2 0.33 3.8 (0.4-37.1)
ACA-IgG >15MPL 5 9 3 5 0.47 2.1 (0.5-9.3)
Prothrombin mutation 1 2 1 2 1.00 1.2 (0.8-20.1)
Factor V Leiden 4 7 1 2 0.17 5.2 (0.6-48.0)
MTHFR mutation 35 65 37 56 0.36 1.4 (0.7-3.0)
Number of values outside the cut-off
value #) none 22 41 45 70 0.01 1 (-)
1 23 43 14 22 0.01 1.0 (0.1-11.4)
2 8 15 3 5 0.01 3.3 (0.3-39.6)
3 1 2 2 3 0.01 5.3 (0.3-82.8)
MTHFR mutation in combination
with other thrombophilic factors
Wild type 19 35 29 45 0.001 1 (-)
MTHFR mutation without other factor 12 22 27 42 0.001 0.2 (0.1-0.6)
MTHRF mutation with other factor(s) 23 43 8 13 0.001 0.1 (0.0-0.4)
#) In the controls there were 2 missing values
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The fact that  some thrombophilic factors, such as Factor V Leiden are present in the
fetus, that can not be demonstrated in the mother,22,23 also contributes to the
concept  of some paternal influence on pregnancy outcome.For example the
expression of genetic thrombophilia in the fetus may have negative influences on the
fetal and intervillous blood circulation, causing vascular disturbances leading to fetal
death. Also thrombosis in early pregnancy may lead to disturbances in the
microcirculation of developing organ systems possibly leading to congenital
malformations in the fetus.
Despite a low prevalence in the normal population for true heritable AT deficiency
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Table 5
Thrombophilic factors in either women or men
Thrombophilic Cut-off Couples cases Couples of P-
factors values (n=54) controls (n=62) value OR (95% c.i.)
no. % no. %
AT <80% 11 20 1 2 0.001 15.3 (1.9-123)
APC-R SR <1.8 22 41 4 7 <0.001 9.6 (3.1-30.4)
PCAct <70% 1 2 1 2 1.00 1.1 (0.1-18.5)
total PSAg <70% 8 15 1 2 0.01 10.4 (1.3-86.0)
free PSAg <20% 2 4 0 0 0.22 ∞
F VIII:C >150% 28 52 21 34 0.09 2.1 (1.0-4.4)
Homocysteine >15µmol/l 4 7 9 15 0.25 0.5 (0.1-1.6)
ACA-IgM >20GPL 4 7 2 3 0.42 2.4 (0.4-13.4)
ACA-IgG >15MPL 9 17 7 12 0.43 1.5 (0.5-4.5)
Prothrombin mutation 3 6 6 10 0.50 0.6 (0.1-2.3)
Factor V Leiden 8 15 8 13 0.79 1.2 (0.4-3.4)
MTHFR mutation 44 82 46 74 0.38 1.5 (0.6-3.7)
Number of values outside the cut-off
value$) no. % no. %
none 8 15 27 45
1 16 30 23 38
2 12 22 6 10
3 12 22 3 5 <0.001 ∞
4 5 9 1 2
5 1 2 0 0
MTHFR mutation in combination
with other thrombophilic factors
Wild type 10 18 16 27 0.01 1 (-)
MTHFR without other factor 8 15 21 35 0.01 0.4 (0.2-1.0)
MTHRF with other factor(s) 36 67 23 38 0.01 0.2 (0.1-0.6)
$) In the controls there were 2 missing values
}
(0.02-0.17%),24 12% of the female cases in our study had low AT levels. Elevated 
F VIII:C  levels are more frequently seen in the blood type Non-O.25 In our study
62% of the female cases and 48% of the control women had  blood type non-O
(p=0.09).This shows that the association with high FVIII:C levels was pre-existent,
and not the result of post-event elevations. Increased APC-resistance was highly
prevalent in the female cases (32% vs 6%).However in only 7 of these 24 cases
(29%)  Factor V Leiden was present and its frequency was not significantly different
as compared to that in controls. So in over 70% the increased APC resistance was
not explained by this mutation.Besides the Factor V Leiden mutation,however, also
acquired risk factors like increased F VIII:C, lupus anticoagulant and oral
contraceptive use are known to induce APC resistance.26 This suggests that
acquired rather than heritable increased APC-resistance is related to perinatal
death.This is in accordance with the raised Factor VIII concentrations found in our
study, as no difference could be demonstrated in the use of oral contraceptives.Our
findings concerning the prothrombin mutation are not in accordance with studies in
which heterozygosity of this mutation has been related to late fetal death.6,10
Our findings about the influence of the MTHFR gene mutation are in accordance
with  the study of Gris et al.9 Heterozygosity for the MTHFR gene mutation may act
as an additional factor in the presence of other thrombophilic defects as folate
requirements are increased and folate stores become partially depleted during
pregnancy. We have no information about the folate intake during the pregnancies
of the female cases or the controls. In the period 1983-1992 the use of peri-
conceptional folic acid suppletion had not yet been recommended as a mass media
campaign started in 1995.27
Hyperhomocysteinaemia is more often described in cases of early pregnancy loss.4,6
This may be an explanation for the fact that we did not find a relation to late fetal-
and early neonatal loss in our study as pregnancy loss already could have occurred
in the first trimester.
The presence of more than one thrombophilic factor was far more frequent in
women with a history of perinatal death (32%) as compared to control women (6%)
(table 3).Combinations of thrombophilic factors like low AT, low free PSAg, low
PCAct, increased APC-R and the presence of ACA’s are often found in relation to
perinatal mortality.9,11,12
Our findings of increased prevalences of thrombophilic abnormalities in couples
with a child who died perinatally show that both parents may contribute to a
hypercoagulable state in both the fetus and the placenta resulting in a fetal loss. As
the distribution of causes of perinatal mortality in the study group of 74 cases was
comparable with the total group of 239 cases,we conclude that thrombophilia in
both men and women is a risk factor for perinatal death.Results of controlled trials
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are needed to assess the effectiveness of interventions in thrombophilia
screen–positive women.So far only the benefit of combined anticoagulant therapy in
antiphospholipid antibodies syndrome is demonstrated.28 As long as no evidence
based primary preventive methods are available,more intensive monitoring may be
indicated as a secondary preventive measure. In cases with a history of perinatal
mortality, evaluation of  the thrombophilic status of both parents should be
determined.
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Chapter 8
History and family history of thromboembolic events
in parents with perinatal mortality
A.E.M.de Galan-Roosen, J.C.Kuijpers, G.A.E.Ponjee,W.A.M.van Beers,
H.A.Bremer, J.M.W.M.Merkus
Abstract
Objective: To determine whether a  personal or a family history of thromboembolic
events is a risk factor for perinatal mortality.
Design: Case control study.
Setting: Dutch healthcare region Delft-Westland-Oostland.
Participants: 74 women and 54 male partners with a history of perinatal death
(cases) and 71 women with previous uncomplicated pregnancies and 66 of their
partners (controls).
Methods: The personal history and family history in first degree relatives concerning
hypertensive disease,preeclampsia and  thromboembolic events  were compared
both in the women as in their male partners using a written questionnaire.
Results: Women with a history of perinatal death reported  significantly more often a
history of a thromboembolic event in the past compared to controls (9 vs 0%,
p=0.01). A positive family history in the first degree (parents and sibs) of
thromboembolic events was reported more frequently by female cases as compared
to controls (49 vs 25%,p=0.004).Mothers and sisters of the female cases reported
far more often an intra-uterine fetal death compared to controls (28 vs 6%,
p < 0.001).Male cases reported  more frequently a family history for
thromboembolic events in the past compared to male controls ( 26 vs 9%,p=0.02).
Conclusions: In women a family history in first degree relatives of thromboembolic
events in the past  or perinatal death is possible a risk factor for perinatal mortality.
A personal history of thromboembolic events and a  family history of
thromboembolic events in the male partner are possible risk factors as well.
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Introduction
Perinatal mortality may be lowered if risk factors for perinatal mortality can be
detected and lead to adequate preventive measures.Maternal thrombophilia may be
considered to be such a risk factor. As much as 65 % of the vascular complications in
pregnancy can be accounted for by thrombophilia.1
These genetic abnormalities can be suspected when thromboembolic events are
present in a personal or family history of a woman.
We demonstrated that paternal thrombophilia is a risk factor in perinatal mortality
as well (chapter 7).
The aim of the current study is to compare the personal and family history with
regard to thromboembolic events in couples,who experienced at least one case of
perinatal death, with a healthy control group without a history of fetal loss.
Methods
Patients and controls:
During the decade of 1983 to 1992 a prospective analysis of perinatal mortality was
performed in the Dutch healthcare region Delft-Westland-Oostland (DWO).
All cases of perinatal death with a birth weight of 500 grams or more (n=239) 
- according to the definition of the World Health Organisation (WHO) for standard
national perinatal death figures -  were included in the study.2The perinatal mortality
rate of the region in that period was 8.25 promille.
Between December 1999 and May 2000,women and their male partners were
asked to participate in this study.Of  59  of the 239 women no recent address could
be traced. Seventy women of the remaining 180 women refused to answer and 36
women refused to participate as they did not want to be reminded of the previous
episode with fetal loss. Seventy-four women (female cases) were included into the
study. Seven women experienced more than one perinatal death.Out of 74
potential male cases 54 could be included.Reasons for non inclusion were: two
males recently died of sudden heart death,10 were divorced and 8 refused
participation because of inconveniences.
Seventy-one control women and 66 of their partners (male controls) were
recruited from public advertisement. All these control women had given birth at
least twice to normal birth weight infants without congenital malformations.They
had no history of fetal loss or recurrent miscarriage.Year of birth had to be between
1950 and 1970 (as women with a history of perinatal mortality were born in the
same period).The study was approved by the institutional medical-ethical
committee and all women and their partners gave informed consent.
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Using a simple written questionnaire (table 1), a history was taken from all
participating women and men: the use of medication, for example oral
contraceptives or estrogens in women was noted.Data concerning the occurrence
of hypertension, thromboembolic events and complications during pregnancies like
preeclampsia and fetal loss, (both personal and family history) were collected.
Statistical analysis was performed with the Statistical Package for Social Sciences for
Windows, version 10.0 (SPSS,Chicago,USA).Categorical data were summarized
with numbers and percentages.Cases were compared to controls using the
Students’ t-test or the Chi-square test. A p-value of < 0.05 was considered
statistically significant.
Results
The characteristics of the female cases and of the female controls are mentioned in
table 2.The results of the questionnaire filled out by the male partners and the
controls are shown in table 3.
There appeared to be a difference in age between the female cases and the controls
(mean 41 vs 39,p=0.02) at the moment  the written interview was taken.There was
no difference in the use of oral contraceptives (24 vs 18%,p=0.42).
A  positive history for a thromboembolic event in the past was reported more
frequently in female cases as compared to female controls ( 9 vs 0%,p=0.01).The
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Table 1
Written questionnaire
General information about the women and men
- age
- use of medication (incl.oral contraceptives, estrogens)  
History of thromboembolic events
- did you ever suffer from venous thrombosis?
- did you ever suffer from pulmonary embolism?
- did you ever suffer from cerebral vascular accidents?
- do you have hypertension?
Obstetrical history of the women (*)
- did you suffer from preeclampsia or pregnancy induced hypertension?
Family history thromboembolic events
- did parents/sibs suffer from thromboembolic events?
- did mother/sisters suffer from recurrent miscarriages (> 1)?*
- did mother/sisters suffer from fetal losses?*
* Questions only answered by the women.
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frequency of  hypertensive diseases including preeclampsia was significantly more
often reported in female cases (16 vs 0%,p=0.001). A positive  family history in the
first degree (parents and sibs) for thromboembolic events was mentioned more
frequently  in female cases as compared to controls ( 49 vs 25%,p=0.004).
Mothers and sisters of female cases far more often reported an intra-uterine fetal
death as compared to controls ( 28 vs 6%,p < 0.001).The percentage of recurrent
miscarriages however was not different (12 vs 18%,p=0.36).
Male cases mentioned  more frequently a positive family history for throm-
boembolic events compared to controls ( 26 vs 9%,p=0.02). Also in couples of
History and family history of thromboembolic events in parents with perinatal mortality
Table 2
Personal- and family history of women with perinatal death as compared to healthy
controls
Characteristic Female Cases * Female Controls P OR
(n=74) (n= 71) value (95% c.i.)
no. % no. %
Age        median 41 39 0.02
range 32-56 27-50
Parity median 3 2
range 2-7 2-4 < 0.001
Oral contraceptive/
estrogens use 18 24 13 18 0.42 1.4 (0.6-3.2)
Personal history of venous
thrombosis, pulmonary
7 9 0 0 0.01 ∞embolism,cerebro-
vascular accidents
Personal history of
hypertension/preeclampsia,
Pregnancy Induced 12 16 0 0 0.001 ∞
Hypertension
Family history of
thromboembolic events. 36 49 18 25 0.004 2.8 (1.4-5.6)
(parents/sibs)
Family history of recurrent
miscarriage in mother/sisters 9 12 13 18 0.36 0.6 (0.3-1.6)
Family history of perinatal
death in mother/sisters 21 28 4 6 <0.001 6.6 (2.12-20.5)
* Women with perinatal death > 500 grams are female cases
}
}
}
}
}
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cases more often a positive family history for thromboembolic events was noted as
compared to control couples (13 versus 3%,p=0.08).
Discussion
In this study we found that  women with a perinatal mortality in the past reported
significantly more often a positive  personal history for thromboembolic events in
the past (venous thrombosis, pulmonary embolism and cerebro-vascular accidents).
Also their family history seemed to be more often positive for thromboembolic
events in first-degree relatives of parents or sibs. In partners of women with a
history of perinatal mortality, significantly more frequently a positive family history
of thromboembolic events was reported compared to control males.The
conclusion in chapter 7 that the risk of thrombophilia is doubled in women as well
as in men with a history of perinatal mortality is in correspondence to this study.
Our study is the first study in which a relation,between a history of
thromboembolic events in the past in women  and in the first degree relatives of
women and men and perinatal mortality is suggested.
A paternal influence on the pregnancy outcome is described in a study showing an
association between preeclampsia and changing paternity.3 Esplin et al. found
evidence for paternal as well as maternal components of the predisposition to
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Table 3
(Family) History of male cases and male controls
Characteristic Male Cases * Male Controls P OR
(n=54) (n= 66) value (95% c.i.)
no. % no. %
Age        median 42 41 0.06
range 35-61 31-53
History of venous thrombosis,
pulmonary embolism, 2 4 1 2 0.59 2.5 (0.2-28.3)
cerebro-vascular-accidents
Personal history of
hypertension 5 9 1 2 0.09 6.6 (0.8-58.6)
Family history of
thromboembolic events. 14 26 6 9 0.02 3.5 (1.2-9.9)
(parents/sibs)
In couples (both in men and women) a positive family history for thromboembolic events was found in 13 vs 3% (p=0.08) O.R.4.5
(95% c.i. 0.9-22.5)
}
}
}
preeclampsia.4 Perinatal mortality can be considered as a family problem as
suggested by the higher incidence of fetal death in mothers and sisters of cases (28%
in the cases versus 6% in the control women p < 0.001).
An important drawback of our study is the fact that self reported information on
medical histories can be subject to recall bias as is shown by studies using medical
records of  the general practioner (GP) in order to assess the quality of self
reported information.5,6This is a limitation of our study, as this recall bias may play a
more important role in the cases-group.
A family history however can be inaccurate as well in the GP medical record as it is
based on indirect information.Confirmation by the relatives GP of the diagnosis
mentioned in the questionnaire will give the most reliable information but is more
difficult to obtain.Therefore our results have to be confirmed by prospective studies
using self reported data and GP data about symptoms,diagnostic tools and
anticoagulant therapy,using tailored standardized questionnaires.7
More attention should be given to the study of  the history and family history of
women and men, concerning the occurrence of thromboembolic events and fetal
death. It may be a useful criterium in the selection of women at possible risk for
complications in pregnancy
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Definition
Perinatal mortality is defined as death surrounding birth. It is divided into death before
birth (stillbirth) and death after birth (neonatal death).Neonatal death can be
divided into early and late neonatal death.Perinatal death figures are calculated per
1000 liveborn or live- and stillborn children.
The definition of perinatal mortality differs in national and international perspective.
The World Health Organisation (WHO) recommended in 1977:‘For international
standardized statistics the term perinatal death should include early neonatal deaths
(within 7 days postnatally) together with those fetal deaths of weight 1000 grams or
more,or if weight is unknown a gestational age of 28 weeks or more or a  crown-
rump length of 35 cm or more’.1 In 1992 the WHO introduced the 10th revision of
the International Classification of Diseases which defines for national data collection
of perinatal mortality the period beginning at 22 completed weeks of gestation (at
this time birth weight is normally about 500 grams) and ending within 7 days
postnatally.2 Many countries,even in Europe,however use definitions that differ from
these WHO recommendations. In the Netherlands all still- and liveborn children
from 24 weeks of gestational age onwards are included in the perinatal death figures
and recorded by the Central Statistics Office of the Netherlands (CBS) (table 1).
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Table 1
Definitions of Perinatal Mortality according to the WHO and CBS  
National perinatal mortality (WHO):
Number of stillborn ≥ 500 gram + number of liveborn ≥ 500 gram dying within 7 x 24 hrs*
Total number of still- and liveborn ≥ 500 gram
Standard international perinatal mortality (WHO) :
Number of stillborn ≥ 1000 gram + number of liveborn ≥ 1000 gram dying within 7 x 24 hrs*
Total number of live- and stillborn ≥1000 gram
Definition of perinatal mortality in the Netherlands before July 1991 (CBS):
Number of stillborn ≥ 28 weeks + number of liveborn dying  within 7 days*
Total number of stillborn ≥ 28 weeks + total number of liveborn
Definition of perinatal mortality in the Netherlands after 1991 (CBS):
Number of live- and stillborn ≥ 24 weeks dying within 7 days*
Total number of live- and stillborn ≥ 24 weeks
* =   X 1000
So the definitions for stillbirth vary both in gestational age (≥16,20,22,24 or 28
weeks) and in birth weight (≥ 500 or ≥ 1000 grams) The criteria for the first-week
mortality vary  from 6 completed days to within 7 days or within 7 x 24 hours. Due
to these various criteria the differences between countries in perinatal mortality
figures can be as much as 30%.3 Because duration of gestation is often unknown or
imprecise and mostly not gestational age but menstrual age is used, a criterion
based on birth weight and gestational age will give more comparable figures than a
criterion based on gestational age alone. As many children survive weighing 500
grams or more,4 a weight criterion of  ≥ 500 grams and/or an age limit of 22 weeks
should be used for the definition of perinatal death. In the Netherlands legislation is
required to ensure registration of birth weight and gestational age of all births. Since
a rather high percentage of the neonatal mortality in the first four weeks takes place
between 7 and 28 days (in the Netherlands about 30%) late neonatal death has to be
included in the perinatal mortality figures as it will give more insight in the
possibilities of support  and treatment of children in the late neonatal period.
The European Board and College of Obstetrics and Gynaecology (EBCOG) should
take the initiative to reach an agreement about the definition of perinatal mortality
in Europe.Only after such an agreement reliable comparisons of perinatal mortality
figures can be made.
Registration 
There are considerable differences in registration reliability (mainly under-
registration) between countries and between regions within countries. As different
definitions are used (see above) clinicians may fail to recognise when a perinatal
death should be registered.5 In the Netherlands underregistration was demonstrated
in several regions. In 1985 Doornbos et al. showed an underregistration in Amsterdam
of 14.3%.6 We showed in 1997 an underregistration in the region Delft-Westland
Oostland of 8.1%.7 Characteristics of the cases that were not registered were a low
birth weight, gestational age on the borderline of registration duty, lethal congenital
malformations and a non-western ethnic background.Even in 2001 incomplete figures
exist because the Neonatal Database of the Netherlands (LNR) is not complete (65%)
and not linked to the Perinatal  Database of the Netherlands primary care (LVR 1,
participation 92%)  and  Perinatal Database of the Netherlands, secondary care (LVR
2, participation 97%).With support of the Dutch Ministry of Health and insurance
companies, the Foundation Perinatal Registration of the Netherlands* was founded
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*)This foundation is represented by: The Dutch Society of Obstetrics and Gynaecology (NVOG), the
Royal Organisation of Midwives in the Netherlands (KNOV), the Dutch GP Association (NHG) and
the Dutch Society of Paediatrics (NVK).
in 2001. In a National Perinatal Registration (Landelijke Perinatale Registratie: LPR),
the LVR-1 and –2  and the LNR will be linked. If the LPR figures are cross-checked
with those from the CBS  a complete registration for the Netherlands can be
expected.7
Uniform definitions  combined with the use of a new national perinatal database will
lead to complete, reliable and comparable perinatal mortality figures.
As long as no agreement about definition and registration of perinatal mortality is
reached, comparison of perinatal mortality rates is only roughly possible after
adjustments for differences in registration laws or publication practices.8
Classification 
In order to obtain a clear understanding of the prevalence of perinatal causes of
death a reliable system for the classification of causes should be used.
A classification of perinatal causes of death was first proposed by Baird et al.9
Since then several classification systems for the registration of perinatal causes of
death have been introduced varying with the specialty of the individuals who
developed them.However,using these systems between 9 and 40% of the causes
remained unclassifiable.10,11 ‘A high proportion of unexplained cases fails to fulfil its
purpose and to help the quest to understand and reduce perinatal mortality’.12
In the Netherlands the causes of perinatal death are registered by the CBS using the
International Classification of Diseases (ICD-10).
Using this CBS classification we found that in 32% of the stillbirth cases the cause of
death was classified as unknown.7We also established  considerable  differences in
the causes of death in comparison with the CBS registration. In 54% of the cases
involving stillbirth and in 32% of the cases involving neonatal mortality, the cause of 
death proved to have been registered in a different way.The registration of causes of
perinatal death in the Netherlands is not adequate in its current form and should be
adapted. A classification system for the registration of perinatal death  should be
based on the underlying cause of death.
We developed such a classification system depending on simple principles of
obstetrical and neonatal pathology. Since the factor that initiated the train of events
leading to death was registered,we called it a fundamental classification system.This
model can be an aid for the classification of causes of perinatal mortality in the
future National  Perinatal Database (Landelijke Perinatale Registratie; LPR).Our
classification system can be used in discussions in clinical pathological conferences
to achieve a high level of agreement in causes of perinatal death.
Using our classification system 3 main causes of perinatal death could be registered
in a Dutch healthcare region Delft-Westland-Oostland considered to be
representative for the Dutch population:placental pathology (53.2%), lethal
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congenital malformations  (23%) and perinatal infections (6.8%).The contribution of
placental pathology to perinatal mortality is often underestimated.Percentages in
literature vary between 10 and 37% depending on the used definitions.10,13 It is very
likely that the diagnose of placental failure is more often made if the placenta is
investigated  profoundly.Registrars in  pathology and in obstetrics and gynaecology
should gain more education in placental pathology.
Concerning congenital malformations we have to conclude that a registration of all
congenital malformations, inclusive those terminated before a gestational age of 22
weeks,does not exist.Therefore, there is no information about the percentage of
congenital malformations leading to fetal death.
A National Perinatal Audit Panel should keep surveillance over prevalences of
(regional) causes of death and substandard care factors in order to assure the
quality of perinatal care within a hospital or a region. In this respect we propose not
to use the term  avoidable in relation to death,but the term suboptimal or
substandard in relation to the delivered care as not avoidable is not synonymous for
optimal care.14
Thrombophilia 
A thrombophilic status of the mother and the fetus is known as a risk factor for
complications in pregnancy.15-18 The paternal role was not yet clarified.We found that
the risk of having thrombophilia is doubled in women as well as in men with a
history of perinatal mortality.Relevant thrombophilic factors appeared to be
antithrombin,protein C activity, total protein S antigen,APC resistance and Factor
VIIII:C. We would not advise to routinely test the C677T mutation in the
methylenetetrahydrofolate reductase gene, since this mutation does not appear to
be an independent risk factor for thromboembolism or fetal death.
If the results of our thrombophilia study and the results of our questionnaire for
thromboembolic events in personal or family history are confirmed it may well be
possible to develop a predictive model for pregnancies at risk for perinatal death.
Such a model should be examined in a large longitudinal follow-up study in pregnant
women both at low and at high risk for perinatal mortality.
Prevention
In order to realize primary prevention women and their partners at risk for
abnormal pregnancy outcome should be detected before the pregnancy or in an early
stage of the pregnancy, if preventive measures are available.The most important
examples of successful primary prevention are the periconceptional use of folic acid,
rubella vaccination, counselling on toxoplasmosis prevention and avoiding
teratogenous medication.
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It can be questioned whether thrombophilia screening of all pregnant women
should be a new primary preventive measure. At this moment the answer is no.
Concerning this question we would like to quote two of the rules of Wilson  &
Jungner: Screening should only be performed in cases where a proper management
can be offered and in cases  the disease forms an important  risk for the general
health status.19
Although a number of case reports claim that prophylactic treatment with heparin
during pregnancies has resulted in successful pregnancy20, at the moment no
randomized controlled trials have proved the benefits of anticoagulant therapy in
cases with known thrombophilic factors in relation to pregnancy outcome.So far
anticoagulant therapy as a preventive measure for fetal loss is only authority based
but not (yet) evidence based.Furthermore as the prevalence of perinatal mortality
is less than 1%, this means that if all pregnant women in the Netherlands were
screened for thrombophilia over 35% ( 70.000) would be declared at possible risk
for perinatal mortality and offered a not evidence based treatment in order to
prevent 500 cases of perinatal mortality, supposed that 25% of the perinatal
mortality is explained by thrombophilia.
Randomized studies will have to prove the benefits and safety of treatment with
anticoagulant therapy during pregnancy in known cases of thrombophilia, before
recommendations for anticoagulant therapy can be made.
The paternal role in adverse pregnancy outcome will have to be further elucidated.
A hypothesis can be that the expression of an inherited paternal thrombophilic
factor in the fetus may have negative influences on the fetal and intervillous blood
circulation, causing vascular disturbances leading to fetal death. Also thrombosis in
early pregnancy may lead to disturbances in the microcirculation of developing
organ systems possibly leading to congenital malformations in the fetus.
Concerning secondary prevention one may wonder whether the current obstetric
system in the Netherlands guarantees adequate risk selection. From our regional
study can be concluded that death during delivery is a relatively rare phenomenon
(0.9/1000,with 3 cases (within 10 years) occurring at home). A strong increase in
medical measures surrounding the parturition will therefore only have marginal
influence on the total perinatal mortality figures. A change of the Dutch perinatal
care should not be sought via a shift to secondary care,but rather in different forms
of co-operation between primary and secondary/tertiary care by improving the
selection criteria based on scientific evidence.The focus should be on the timely
detection of serious congenital malformations in the fetus prior to 20 weeks of
gestation and on developing clinically useful gauges for detecting progressive
placental failure.21
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One should realize that perinatal mortality is the most extreme form of adverse
pregnancy outcome. As perinatal morbidity and –mortality are related,measures
with an aim of prevention of perinatal mortality will also contribute to a decrease in
perinatal morbidity.
In conclusion
• Agreement about a uniform definition of perinatal mortality is urgently needed.
• Comparison of perinatal mortality figures between countries has no sense if the
definitions are not uniform and the registration is not complete.
• Perinatal Audit Panels should give insight in both the quality of the delivered care
and in the underlying causes of death using a classification system based on these
causes.
• The father contributes to thrombophilia related perinatal mortality almost as
much as the mother.
• During preconceptional counselling more attention is needed for the history and
family history of the future parents concerning thromboembolic events and fetal
death.
• The role of maternal and paternal thrombophilia in perinatal mortality and the
importance of the (family)history of thromboembolic events as selection
criterion for pregnancies at risk should be further elucidated.
Epilogue
Literature
1. Definition of perinatal mortality. Lancet 1977;2:353-54.
2. World Health Organisation (WHO). International Classification of Diseases,10th ed.Geneva:
WHO,1992.
3. Richardus JH,Graafmans WC,Verloove-Vanhorick SP,Mackenbach JP.The perinatal mortality rate as
an indicator of quality of care in international comparisons.Med Care 1998;36:54-66.
4. Scientific Steering Committee of the National Neonatal Register. Increase in preterm birth in the
Netherlands in 1993 compared with 1983.Ned Tijdschr Geneeskd 1998;142:127-31.
5. Keirse MJ.The Dutch perinatal mortality in an international perspective.Ned Tijdschr Geneeskd
1987;131:905-09.
6. Doornbos JP,Nordbeck HJ,Treffers PE.Reliability of the registration of perinatal mortality in the
Netherlands, studied for the municipality of Amsterdam.Ned Tijdschr Geneeskd  1987;131:913-7.
7. Galan-Roosen AEM de,Kuijpers JC,Oei YB, van Velzen D,Mackenbach JP.Discrepancy between
results of registration of perinatal cause of death by the CBS (Central Bureau of Statistics) and by
personal studies in the Delft-Westland-Oostland region.Ned Tijdschr Geneeskd 1997;141:237-40.
8. Graafmans WC,Richardus JH,Macfarlane A,Rebagliato M,Blondel B,Verloove-Vanhorick SP et al.
Comparability of published perinatal mortality rates in Western Europe: the quantitative impact of
differences in gestational age and birthweight criteria.BJOG.2001;108:1237-45.
9. Baird D.The causes and prevention of stillbirths and first week deaths. J Obstet Gynaecol Br
Empire 1954;61:433-48.
10. Hovatta O,Lipasti A,Rapola J,Karjalainen O.Causes of stillbirth: a clinicopathological study of 243
patients.Br J Obstet Gynaecol 1983;90:691-96.
11. Wigglesworth JS.Monitoring perinatal mortality. A pathophysiological approach.Lancet
1980;2:684-86.
12. Confidencial Enquiry into Stillbirths and Deaths in Infancy:8th Annual Report, 1 January- 31
december 1999.London:Maternal and Health Research Consortium,11-19.2001.
13. Naeye RL.Causes of perinatal mortality in the US Collaborative Perinatal Project. JAMA
1977;238:228-29.
14. Richardus JH,Graafmans WC,van der Pal-de Bruin KM,Amelink-Verburg MP,Verloove-Vanhorick
SP,Mackenbach JP. An European concerted action investigating the validity of perinatal mortality as
an outcome indicator for the quality of antenatal and perinatal care. J Perinat Med 1997;25:313-24.
15. Martinelli I,Taioli E,Cetin I,Marinoni A,Gerosa S,Villa MV et al.Mutations in coagulation factors in
women with unexplained late fetal loss.N Engl J Med  2000;343:1015-18.
16. Vries JIP de,Dekker GA,Huijgens PC, Jakobs C,Blomberg BMEv,Geijn HPv.Hyperhomocysteinaemia
and Protein S deficiency in complicated pregnancies.Br J Obstet Gynaecol 1997;104:1248-54.
17. Kupferminc MJ, Eldor A,Steinman N,Many A,Bar-Am A, Jaffa A et al. Increased frequency of genetic
thrombophilia in women with complications of pregnancy.N Engl J Med  1999;340:9-13.
18. Dizon-Townson DS,Meline L,Nelson LM,Varner M,Ward K.Fetal carriers of the factor V Leiden
Mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol  1997;177:402-
05.
19. Wilson, JMG and Jungner,YG.Principles and practice of screening for disease.Geneva:World
Health Organisation, Public Health Papers, 1968,no.34.
20. Bonnar J,Green R,Norris L. Inherited thrombophilia and pregnancy: the obstetric perspective.
Semin Thromb Hemost 1998;24 (Suppl 1):49-53.
Chapter 9
110
21. Galan-Roosen AEM de,Kuijpers JC,Mackenbach JP.Perinatal mortality in Delft and surrounds,
1983-1992: further reduction is possible by targeting lethal congenital abnormalities and placental
insufficiency.Ned Tijdschr Geneeskd 1999;143:152-7.
Epilogue
111
Summary
Chapter 1 -  General Introduction
The extent of the problem is described. Although the perinatal mortality figures
have shown a strong decline in the western world, in the Netherlands still
approximately 1400 cases a year occur,which means a loss of almost 4 children a
day.Perinatal mortality is still used as a quality parameter for obstetric and neonatal
care.The problems in the definition, registration and classification of perinatal
mortality are discussed and the consequences related to comparison of
international perinatal mortality rates are discussed.
Chapter 2 - Reliability of  Dutch perinatal mortality registration by the
Central Statistics Office (CBS)
The reliability of the Dutch registration of causes of perinatal death by the Central
Statistics Office was investigated. In the region Delft-Westland-Oostland (DWO) in
the Netherlands a prospective 10 years study was performed concerning all cases of
perinatal mortality.By linking, in retrospect, a prospective regional registration
system for perinatal mortality within the region anonymously to the CBS
registration, the reliability of the latter registration regarding causes of death was
determined.The registration of the causes of death regarding perinatal mortality
and particularly stillbirth by the CBS shows gaps,mostly due to incorrect reporting
of the cause of death by the treating physician or autopsist, due to the fact that at
the time of notification the pathological-anatomical diagnosis and/or laboratory data
were often not complete. For the study of the backgrounds of perinatal mortality
the current CBS registration of causes of death appears unsuitable.
Chapter 3 - Distribution of perinatal mortality over various levels of
obstetric care
A prospective regional registration system for perinatal mortality in the region
DWO was matched with the registration of the CBS.The causes of death were
assessed by a gynaecologist, a paediatrician and a fetal pathologist. It was
determined for all cases of perinatal mortality whether the antenatal care had been
under the final responsibility of a midwive or a general practitioner (primary care),
either at home or in a hospital, or under the final responsibility of a gynaecologist
(secondary care). In 26%  of the cases of perinatal mortality the perinatal care was
managed under primary care responsibility, in 43% after risk selection from primary
to secondary care, in 14% under the exclusive responsibility of secondary care and
in 17% after risk selection from secondary to tertiary care.The most frequent
causes of death were progressive placental insufficiency and lethal congenital
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malformations. Further decrease of perinatal mortality may be achieved by risk
selection in primary care for these categories. Transferring the home confinement
to hospital will offer little or no improvement in the area of perinatal mortality.
Chapter 4 - Contribution of congenital malformations to perinatal
mortality
The contribution of congenital malformations to perinatal mortality in a Dutch
healthcare region was determined.Malformations were classified as lethal or
nonlethal  and recorded separately for stillbirth (from 28 weeks gestation) and
liveborn infants dying within 7 days postnatally.The overall incidence of congenital
malformations (major and minor) in the perinatal mortality group was 33%.The
congenital malformations were classified as lethal in 51% of the stillbirths and 70% of
the neonatal deaths.Congenital malformations of the central nervous system are
most frequent in the stillbirth group.Cardiovascular and pulmonary malformations,
resulting in perinatal death, are more prominent in the neonatal period.Urogenital
and minor malformations (miscellaneous) were more often seen in perinatal deaths
without being a contributor to the cause of death.
Chapter 5 - Fundamental classification of perinatal death 
A new classification system for the registration of causes of perinatal mortality was
validated. In a ten years period all cases of perinatal mortality with a birth weight of
500 grams or more were included in the study. Six assessors (4 gynaecologists and 2
paediatricians) classified all cases using a classification model developed by us and
based upon the underlying cause of death.This model uses simple principles of
obstetrical and neonatal pathology:birth trauma, infection,placenta or cord
pathology,pathology of immune tolerance of the mother and fetus, congenital
malformation and complications of a previable delivery. Agreement beyond chance
between assessors was calculated using Kappa ’s coefficient for multiple observers
and multiple test results.Overall Kappa was 0.70 (95% c.i. 0.68-0.72).Reproducibility
was poor for the categories trauma and unclassifiable, fair to good for the categories
infections and placenta/cord pathology and very good to excellent for the
categories maternal immunesystem pathology, congenital malformations and
complications of prematurity.The proposed system showed a good level of
agreement. It will enable (inter)national comparisons in causes of perinatal death.
Chapter 6 -  Evaluation of 239 cases of perinatal death
During the period 1983-1992 all cases of perinatal mortality with a birth weight of
500 grams or more (n=239) were classified in a new fundamental classification
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system as described in chapter 4. A team consisting of a gynaecologist,
neonatologist and pathologist classified all cases of perinatal death in 7 groups to
determine the most probable cause of death.Birth trauma and bloodtype
antagonism were each seen in 0.8% and infection in 6.8%,complications of a pre-
viable delivery in 8.4% of the cases. Lethal congenital malformations were an
important group with 23%, together with placenta pathology in 53% of the cases,of
which  21%  acute/subacute and 32% chronic placental pathology.Unclassifiable was
7% of the cases.Classification of  causes of perinatal death by using this fundamental
classification system gives insight in the possible underlying causes of death.The
results of such a classification can be used as guidelines for preventive measures in
the near future.
Chapter 7-  Maternal and paternal thrombophilia 
In a case-control study the prevalence of thrombophilia was studied in 74 women
with perinatal death (female cases) and 54 of their male partners (male cases) which
were compared to 71 healthy women with uneventful pregnancies and 66 of their
male partners. Female cases more often had levels outside the reference range than
controls for low levels of antithrombin  and total protein S, increased APC
resistance and high factor VIII:C.Male partners of cases also more often had
increased APC-resistance than controls. In couples with a history of perinatal death
more frequently two or more thrombophilic abnormalities were found as compared
to couples of the control group.The risk of having thrombophilia is doubled in both
parents (women as well as men) with a history of perinatal mortality.
Chapter 8 -  History and family history of thromboembolic events in
parents with perinatal mortality
In a case-control study of 74 women with a history of perinatal death (female cases)
and 54 of their male partners (male cases)  the personal- and family history in first
degree relatives concerning hypertensive disease,preeclampsia and thrombo-
embolic events were compared to those of 71 healthy women (female controls)
with uneventful pregnancies and 66 of their partners (male controls) by using a
written questionnaire. In women a history of a thromboembolic event in the past
was reported more often in cases as compared to controls. A positive family history
in the first degree of thromboembolic events was reported more frequently in
female cases as compared to controls.Mothers and sisters of the female cases more
often reported an intra-uterine fetal death as compared to mothers and sisters of
controls.Male cases reported more frequently a positive family history for
thromboembolic events in the past as compared to male controls.
Chapter 9
In women a family history  in first degree relatives of thromboembolic events in the
past or perinatal death seems to be a risk factor for perinatal mortality. A  history
or family history of thromboembolic events in the male partner is a possible risk
factor as well.
Chapter 9 -  Epilogue
Recommendations are given for the definition, registration and classification  of
perinatal mortality in the Netherlands.The possible consequences of thrombophilia
are outlined especially in relation with risk selection.
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Samenvatting
Hoofdstuk 1 -  Algemene Inleiding
De omvang van het probleem perinatale sterfte wordt beschreven.Hoewel de
perinatale sterftecijfers in de westerse wereld sterk zijn gedaald, treden in
Nederland toch nog altijd ongeveer 1400 gevallen van perinatale sterfte per jaar op.
Dit betekent een verlies van bijna 4 kinderen per dag.De hoogte van de perinatale
sterftecijfers wordt gezien als kwaliteitsgraadmeter voor obstetrische en neonatale
zorg.De belangrijkste doelstellingen van het proefschrift worden beschreven.
De problemen in de definitie, registratie en classificatie van perinatale sterfte en de
consequenties ervan voor het vergelijken van perinatale sterftecijfers van landen
worden besproken.
Hoofdstuk 2 -  De betrouwbaarheid van de Nederlandse perinatale
sterfte registratie door het Centraal Bureau voor de Statistiek (CBS)
De betrouwbaarheid van de Nederlandse registratie van doodsoorzaken door het
CBS werd onderzocht. In de regio Delft-Westland-Oostland (DWO) van Nederland
werd een prospectieve studie gedurende 10 jaar verricht waarin alle voorgekomen
gevallen van perinatale sterfte werden betrokken.Door achteraf een prospectief
regionaal registratiesysteem voor perinatale sterfte voor de desbetreffende regio
anoniem te koppelen aan de registratie van het CBS,werd de betrouwbaarheid van
deze laatste registratie bepaald ten aanzien van de vermelde doodsoorzaken.De
doodsoorzakenregistratie van perinatale sterfte door het CBS,en met name van
doodgeboorte, kent tekortkomingen.Dit wordt voornamelijk veroorzaakt door het
onjuist aanleveren van de diagnose door de behandelende of schouwende arts,
doordat op het moment van de aangifte de pathologisch-anatomische diagnose en
(of) laboratoriumgegevens nog niet alle bekend zijn.Voor het bestuderen van de
achtergronden van perinatale sterfte lijkt de huidige CBS-doodsoorzakenregistratie
niet geschikt.
Hoofdstuk 3 -  Verdeling van perinatale sterfte over de verschillende
echelons van verloskundige zorg
Een prospectief regionaal registratiesysteem voor perinatale sterfte binnen de regio
DWO werd gekoppeld aan de registratie  van het Centraal Bureau voor de
Statistiek (CBS).De doodsoorzaken werden beoordeeld door een gynaecoloog,een
kinderarts en een kinderpatholoog.Bij alle gevallen van perinatale sterfte werd
nagegaan of de antenatale zorg op dat moment plaatsvond onder
eindverantwoordelijkheid van een verloskundige of een huisarts (eerste lijn) zowel
thuis als poliklinisch,dan wel onder eindverantwoordelijkheid van een gynaecoloog
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(tweede lijn). In 26% van de gevallen vond de bevalling plaats onder
verantwoordelijkheid van de eerste lijn, in 43% na risicoselectie vanuit de eerste lijn
naar de tweede lijn, in 14% uitsluitend onder verantwoordelijkheid van de tweede
lijn en in 17% na risicoselectie vanuit de tweede naar de derde lijn.De meest
voorkomende doodsoorzaken waren progressieve placenta-insufficiëntie en letale
congenitale afwijkingen.Verdere reductie van perinatale sterfte kan worden bereikt
door risicoselectie  (in de eerste lijn) met het oog op deze meest voorkomende
doodsoorzaken.Verdere medicalisering van de partus zal maar weinig aan een
verdere daling van de perinatale sterftecijfers kunnen bijdragen.
Hoofdstuk 4 -  De bijdrage van congenitale afwijkingen aan de perinatale
sterfte
De bijdrage van congenitale afwijkingen aan de perinatale sterfte in een
Nederlandse gezondheidszorgregio werd vastgesteld. Afwijkingen werden
geclassificeerd als letaal en niet-letaal en vervolgens afzonderlijk vastgelegd voor
doodgeboren (vanaf 28 weken) en levendgeboren kinderen die binnen 7 dagen na de
geboorte overleden waren.De incidentie van  alle congenitale afwijkingen (zowel
grote als kleine) in de groep met perinatale sterfte bleek 33% te zijn. In 51% van de
gevallen van doodgeboorte werden de congenitale afwijkingen geclassificeerd als
letaal.Bij de neonatale sterfte bleek dat in 70% van de gevallen te zijn gebeurd.
Congenitale afwijkingen van het centraal zenuwstelsel kwamen vooral voor in de
doodgeboorte groep.Letale cardiovasculaire en pulmonale afwijkingen bleken
vooral voor te komen bij neonatale sterfte.Urogenitale afwijkingen en allerhande
kleine afwijkingen werden vaker gezien zonder dat ze de doodsoorzaak waren.
Hoofdstuk 5 -  Een fundamenteel classificatiesysteem voor perinatale
sterfte
Een nieuw systeem voor de registratie van oorzaken van perinatale sterfte werd
gevalideerd.Gedurende een periode van 10 jaar werden alle gevallen van perinatale
sterfte met een geboortegewicht van 500 gram en meer gebruikt voor de studie.
Zes beoordelaars (4 gynaecologen en 2 kinderartsen) classificeerden alle gevallen
van perinatale sterfte  aan de hand van een nieuw, fundamenteel, classificatiemodel
dat is  gebaseerd op de onderliggende doodsoorzaak.Dit model maakt gebruik van
eenvoudige principes van obstetrische en neonatale pathologie: geboortetrauma,
infectie, placenta of navelstrengpathologie, immuuntolerantie tussen moeder en
kind, congenitale afwijkingen en complicaties van vroeggeboorte.
Overeenstemming tussen beoordelaars werd  berekend met behulp van Kappa ’s
coëfficiënt voor multipele waarnemers en multiple testresultaten.De totale kappa
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was 0.70 (95% betrouwbaarheidsinterval 0.68-0.72).De reproduceerbaarheid was
slecht voor de categorieën geboortetrauma en niet-classificeerbaar, voldoende tot
goed voor de categorieën infectie en placentapathologie en erg goed tot uitstekend
voor de categorieën immuuntolerantie moeder/kind, congenitale afwijkingen en
complicaties van vroeggeboorte.Het voorgestelde systeem toonde een goed niveau
van overeenstemming.Het systeem maakt (inter)nationale vergelijkingen van
doodsoorzaken mogelijk.
Hoofdstuk 6 -  De evaluatie van 239 gevallen van perinale sterfte
Betreffende de jaren 1983-1992 werden alle gevallen van perinatale sterfte met een
geboortegewicht van 500 gram en meer (n=239) ingedeeld in een
classificatiesysteem zoals is beschreven in hoofdstuk 4.Een team bestaande uit een
gynaecoloog,een neonatoloog en een patholoog classificeerde alle gevallen van
perinatale sterfte binnen 7 hoofdgroepen teneinde de meest waarschijnlijke
doodsoorzaak vast te leggen.Geboortetrauma  en bloedgroepantagonisme kwamen
elk in 0,8% van de gevallen voor, infectie in 6,8% van de gevallen en complicaties van
extreme vroeggeboorten werden in 8,4% van de gevallen gezien.
Letale congenitale afwijkingen vormen een belangrijke groep met 23% van de
gevallen.De grootste groep vormt de placentapathologie met 53%,waarvan 21%
chronisch en 32% acuut/subacuut optredend. In 7% van de gevallen bleek classificatie
niet mogelijk.Bij de classificatie van oorzaken van perinatale sterfte,waarbij gebruik
wordt gemaakt van dit fundamentele classificatiesysteem,wordt goed inzicht
verkregen in de mogelijk onderliggende doodsoorzaak.De resultaten van zo een
classificatiesysteem kunnen gebruikt worden als uitgangspunten voor preventieve
maatregelen in de nabije toekomst.
Hoofdstuk 7 -  Maternale en paternale trombofilie
De prevalentie van trombofilie werd bestudeerd in een patiënt-controle studie
waarbij 74 vrouwen met een voorgeschiedenis van perinatale sterfte  en 54 van hun
mannelijke partners  werden vergeleken met 71 vrouwen met een of meer
ongestoorde zwangerschappen in het verleden en hun 66 mannelijke partners.
Vrouwen met een perinatale sterfte in de voorgeschiedenis hadden vaker waarden
buiten het referentie-gebied dan vrouwen uit de controlegroep,met name lage anti-
thrombine waarden en totale proteine S waarden, toegenomen APC-resistentie en
hoge factor VIII concentraties.Mannelijke partners van die vrouwen hadden
eveneens vaker toegenomen APC-resistentie vergeleken met de partners van de
vrouwen uit de controlegroep.Bij paren (vrouw en man) met een voorgeschiedenis
van perinatale sterfte werden vaker 2 of meer trombofilie afwijkingen gevonden in
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vergelijking met paren uit de controlegroep.
Zowel een man als een vrouw met een perinatale sterfte in de voorgeschiedenis
hebben een tweemaal zo hoog risico op trombofilie als ouders met een
ongestoorde zwangerschap in het verleden.
Hoofdstuk 8 -  Anamnese en familie-anamnese voor trombo-embolische
processen bij ouders met een voorgeschiedenis van perinatale sterfte
Vierenzeventig  vrouwen met een voorgeschiedenis van perinatale sterfte  en 54 van
hun mannelijke partners noteerden in een patiënt-controle onderzoek de gegevens
van de persoonlijke- en de familie-anamnese betreffende het voorkomen van
hypertensieve aandoeningen,preeclampsie en trombo-embolische processen bij
eerstegraads familieleden.Deze gegevens werden vergeleken met die van  71
gezonde vrouwen (controles) met ongecompliceerde zwangerschappen in het
verleden en hun 66 mannelijke partners.Hierbij werd gebruik gemaakt van een
eenvoudige schriftelijke vragenlijst.Het voorkomen van trombo-embolische
processen werd door de vrouwen met perinatale sterfte in de anamnese vaker
genoemd dan door de vrouwen die in het verleden een ongestoorde zwangerschap
doormaakten.Een positieve familie-anamnese voor trombo-embolische processen
in het verleden bij eerstegraads familieleden werd vaker gemeld in de studiegroep
vergeleken met de controlegroep.Moeders en zussen van vrouwen met een
voorgeschiedenis van perinatale sterfte meldden eveneens vaker dat zij een intra-
uteriene vruchtdood hadden doorgemaakt.Mannelijke partners van die vrouwen
meldden vaker een positieve familie-anamnese voor trombo-embolische processen
in vergelijking tot partners uit de controlegroep.Het lijkt er dus op dat een
dergelijke anamnese een risicofactor is voor perinatale sterfte.
Hoofdstuk 9 -  Epiloog
Voor de definitie, registratie en classificatie van perinatale sterfte in Nederland
worden aanbevelingen gedaan.De mogelijke gevolgen van trombofilie met name
voor risicoselectie worden uiteengezet.
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Reinier de Graaf Gasthuis te Delft.Vanaf september 1991 tot september 1994 was
zij in opleiding in het Dijkzigt Ziekenhuis Rotterdam (opleider Prof. dr.H.C.S.
Wallenburg) hierna vervolgde zij de opleiding in respectievelijk het Reinier de Graaf
Gasthuis (opleider dr. J.C.Kuijpers) en het St. Franciscus Gasthuis te Rotterdam
(opleider dr. A.Th. Alberda) alwaar zij in september 1997 de opleiding tot
gynaecoloog afrondde. Sinds 1997 is zij werkzaam als gynaecoloog in het Twee
Steden Ziekenhuis te Tilburg.Zij is gehuwd met Nand de Galan en moeder van Julie-
Anne (1996) en Emilie (1999).
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Aan het einde van een lange onderzoeksperiode wil ik iedereen die een bijdrage
heeft geleverd aan de totstandkoming van dit proefschrift bedanken.
In feite werd de basis voor dit proefschrift reeds gelegd in de begin jaren ’80 door
Johan Kuijpers,Piet van der Straaten en Dick van Velzen. Als beginnende AGNIO
kon ik onder jullie enthousiasmerende leiding hieraan deelnemen.
Zonder de niet aflatende enthousiaste, volhardende, leerzame en bovenal gezellige
begeleiding van mijn co-promotor Johan Kuijpers was dit nooit gelukt! Johan,het
heeft je een groot aantal jaren inspanning gekost, zeer veel dank hiervoor.
In een later stadium kregen we op aanraden van collega Hans Kock zeer veel steun
en inspiratie van zijn oud-collega en vriend Prof. dr.Hans Merkus.Hans, als mijn
promotor was jouw enthousiasme, inzicht,werklust en warme betrokkenheid
onovertroffen.Door jouw nieuwe impulsen is het boekje er uiteindelijk toch
gekomen.Mijn dank is groot!
Natuurlijk had het onderzoek er nooit gekomen als niet vele patiënten en hun
partners uit Delft en omstreken hadden willen meewerken aan dit langlopende
onderzoek.Helaas hebben zij allen het verlies van een of meerdere kinderen in hun
leven moeten meemaken,hun lot maakte dat de stimulans om dit probleem in deze
studie aan de kaak te stellen des te groter werd.Ook de groep van gezonde
vrijwilligers en hun partners wil ik danken.
De mensen van het afnamelab en klinisch chemisch lab in zowel Delft als Tilburg
hebben goed werk verricht om de latere studies mogelijk te maken.
De klinisch chemici Gabrielle Ponjee en Jacqueline de Jongh dank ik voor al hun
inspanningen bij het  zorgvuldig laten uitvoeren van alle lab bepalingen.
Wil van Beers wil ik speciaal bedanken voor zijn tomeloze inzet bij het uitvoeren
van de statistische bewerkingen.Ook al vroegen we je steeds weer nieuwe
combinaties te berekenen,niets was je te veel!
De secretaressen Astrid, Angela en Unia wil ik danken voor het maken van alle
afspraken en het aannemen van lastige telefoontjes.
Ria Kuijpers wil ik danken voor haar crisis-interventie bij het afronden van het
manuscript, dankzij jouw punctualiteit ziet het er nu mooi uit!
Hans Houtzager wil ik hartelijk danken voor zijn aandeel in de fraaie voorzijde van
dit boekje.
De hooggeleerden van den Bosch,Holm,Bruinse en Zielhuis en de zeergeleerde
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Steegers wil ik danken voor hun waardevolle kritische bijdragen bij de beoordeling
van het uiteindelijke manuscript.
De collega’s in Tilburg en Delft bleven ondanks het langdurige traject toch altijd zeer
belangstellend en ondersteunend.Dank voor de ruimte, tijd en support die jullie mij
altijd maar weer hebben geboden, ik waardeer jullie zeer!
De paranimfen Thierry en Cora, vrienden én collega’s wil ik danken voor het in raad
en daad bijstaan wanneer het weer eens gisteren af moest zijn.
Als één na laatste natuurlijk alle vrienden en familieleden, jullie waren soms ook het
spoor bijster met betrekking tot dit boekje.Doordat jullie er altijd toch op het juiste
moment voor me waren, is het uiteindelijk gelukt!
Als laatste wil ik Nand mijn excuus maken, sorry dat het zo lang heeft geduurd,dank
voor al je support en liefde. Ik maak het weer goed,het leven is té mooi…..
Julie en Emilie,mamma kan nu eindelijk weer mee gaan zwemmen in Dongen!
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